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Abstract
β-Galactosidase of Escherichia coli is the equivalent of lactase in humans and
has the ability to bind and hydrolyse lactose. Lactase deciency is a com-
mon phenomenon present in almost 70 % of the world's population. This has
resulted in greater than before demands on the food processing industry to
develop a method that will allow for the hydrolysis of the disaccharide lactose
in milk but will also allow for the removal of the remaining active enzyme.
In this thesis, a new method, that is bio-specic and well characterized
for the removal of lactose from a lactose containing solution, is described.
The E537D mutated version of β-Galactosidase, which has a much lower
activity compared to the wildtype and is able to bio-specically bind lac-
tose for longer periods, was covalently immobilised to commercially available
magnetic nanoparticles (uidMAG-Amine) via two coupling strategies. Glu-
taraldehyde is a cross-linking agent that reacts with amine groups, while N-
(3-Dimethylaminopropyl)-N'-ethylcarbodiimide hydrochloride (EDC) is a cou-
pling agent that activates carboxylic groups. These agents are widely used for
the coupling of biomolecules to solid supports.
The covalently coupled uidMAG-E537D β-Galactosidase particles were
characterized regarding retained enzymatic activity and ability to bind and
physically remove lactose from a lactose containing solution by applying an
external magnetic eld, after lactose binding, to the enzyme-particle complex
in solution.
Each component aimed at yielding this functionally immobilised enzyme
complex was studied and optimized to contribute to the development of this
novel technique, which is aordable and simple, for the removal of lactose from
solution for the ultimate production of lactose free milk.
Results indicated the glutaraldehyde method of β-Gal cross-linking to uidMAG-
Amine to be the preferred strategy since it allowed an increased carrier capacity
of protein to the particles. The glutaraldehyde cross-linked protein also exhib-
ited a two-fold higher activity than the EDC coupled protein. Furthermore,
the glutaraldehyde cross-linked uidMAG-E537D β-Gal was able to physically
remove 34 % of the lactose from a 0.2 nmol/L lactose in solution. This, there-
fore, conrmed the potential use of this novel technique in the food processing
industry.
ii
Stellenbosch University  http://scholar.sun.ac.za
Opsomming
β-Galaktosidase vanaf Escherichia coli is dieselfde as laktase in mense en be-
skik oor die vermoë om laktose te bind en te hidroliseer. 'n Gebrek aan laktase
kom algemeen voor en ongeveer 70 % van die wêreldbevolking ly hieraan. Laas-
genoemde het daartoe gelei dat daar meer druk as vantevore op die voedsel-
produksie industrie is om 'n metode te ontwikkel waarmee die hidrolise van
die disakkaried laktose in melk moontlik sal wees asook die verwydering van
die oorblywende aktiewe ensiem.
In hierdie tesis word 'n nuwe metode beskryf wat biospesiek en goed ge-
karakteriseer is vir die verwydering van laktose vanuit 'n laktose bevattende
oplossing. Die E537D gemuteerde weergawe van β-Galaktosidase, wat beskik
oor 'n baie laer aktiwiteit as die wildetipe asook die vermoë om laktose biospe-
siek vir langer periodes te bind, is kovalent geïmmobiliseer op kommersieel
beskikbare magnetiese nanopartikels (uidMAG-Amine) via twee koppelings-
strategieë. Glutaraldehied is 'n kruisbindingsagent wat met amino groepe rea-
geer, terwyl EDC 'n koppelingsagent is wat karboksie groepe aktiveer. Hierdie
agente word algemeen gebruik vir die binding van biomolekules aan soliede
matrikse.
Die kovalent gekoppelde uidMAG-E537D β-Galaktosidase partikels is ge-
karakteriseer met betrekking tot behoue ensimatiese aktiwiteit en vermoë om
laktose te bind en sies te verwyder vanuit 'n oplossing wat laktose bevat deur
'n eksterne magneetveld op die ensiem-partikel kompleks in oplossing toe te
pas, nadat die binding van laktose plaasgevind het.
Elke komponent van hierdie funksioneel geïmmobiliseerde ensiemkomplekse
is ondersoek en geoptimaliseer met die doel om by te dra tot die ontwikkeling
van 'n nuwe tegniek wat bekostigbaar en eenvoudig is vir die verwydering van
laktose vanuit 'n oplossing vir die uiteindelike gebruik in die produksie van
laktose-vrye melk.
Resultate het getoon dat die glutaraldehied metode van β-Gal kruisbinding
op uidMAG-Amine verkies word aangesien dit 'n verhoogde draerkapasiteit
van proteïene op die partikels moontlik maak. Die glutaraldehied gekoppelde
proteïene beskik ook oor twee keer meer aktiwiteit as die EDC gekoppelde
proteïene. Die glutaraldehied gekoppelde uidMAG-E537D β-Gal kon 34 %
van die laktose teenwoordig in 'n 0.2 nmol/L laktose oplossing sies verwy-
der. Hierdie het dus die potensiële gebruik van hierdie nuwe metode in die
voedselproduksie industrie bevestig.
iii
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There is a growing demand for lactose free/reduced products in the world
today. This is due to the majority of the world's population (70 %) being
unable to digest signicant amounts of lactose (the disaccharide sugar in milk).
Lactose intolerance is caused by inadequate amounts of lactase, which is an
enzyme responsible for the digestion of lactose, being expressed in the small
intestinal villi. Interestingly the degree of lactase deciency diers between
patients. It has been shown that there are three main types of lactase de-
ciency: primary, secondary and congenital [1]. Gastrointestinal symptoms are
the most common eect of the malabsorption of dietary lactose in the small
intestine due to the lack of or insucient lactase expression [1].
The most common type of lactose intolerance, primary adult type, var-
ies signicantly between individuals from dierent areas/regions as well as
between dierent ethnic groups [2; 3]. According to Swagerty et al. [1], it
is present in 15 percent of Northern Europeans, 80 percent of Blacks and
Latinos and up to 100 percent of Asians and American Indians. Simoons [2]
hypothesized that this phenomenon is due to historical milking habits and ge-
netic selection. Research has indicated that populations from areas (Europe
1
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and Africa) that milked dairy animals (cows, goats, sheep and water bualo)
and consumed these dairy products in the period roughly from 4000 to 1200
BC have low incidents of adult lactose intolerance [2]. In contrast to this, high
incidences of lactose intolerance occur in adults in traditionally non-milking
areas i.e. the Pacic, East and Southeast Asia and the New World [2]. It
therefore seems likely that the global variation in lactose intolerance may have
resulted from a genetic basis for primary adult lactose intolerance accompan-
ied by a form of selection for tolerance due to milking habits to allow for the
consumption of lactose-rich dairy products.
1.2 Current practice in the production of
lactose free products
Currently, some lactose free/reduced products are on the market. The man-
ufacturers of these products (example EasyGest, Parmalat SA (Pty) Ltd.)
generate these by adding the free lactase enzyme to the milk. This enzyme
breaks down the lactose into glucose and galactose (monosaccharide sugars),
which the body can absorb. Some lactose free milk producing companies in-
clude several ultra-centrifugation steps after the complete hydrolysis of the
lactose present. This step removes some of the excess monosaccharide sugars.
Unfortunately, due to the higher relative sweetness of glucose and galactose in
comparison to lactose, the resulting product is very sweet. A consumer study
revealed that this very sweet taste is perceived as negative. This aspect will
be discussed in greater detail in Chapters 2 and 3.
1.3 Focus of this study
The central idea at the start of this study was to develop a novel technique
for the removal of lactose from milk to contribute to, and boost, the food
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processing industry with regards to the production of lactose free/reduced
dairy products.
Lactose, the sugar for which the intolerance is named, is converted to gluc-
ose and galactose via enzymatic hydrolysis. This creates a new problem due
to the higher relative sweetness of the combination of glucose and galactose as
compared to lactose.
This novel method would include the removal of a portion of the lactose
from milk while minimising the hydrolysis to glucose and galactose. It is im-
portant, however, that some of the lactose is hydrolyzed to the monosaccharide
sugars in order to account for the loss in sugar caused by the removal of lactose.
To accomplish lactose binding but minimise lactose hydrolysis, a E537D
mutated form of β-Galactosidase (β-Gal) will be used that exhibits much lower
hydrolysis activity compared to the wildtype β-Gal, but similar substrate bind-
ing capabilities. For the removal of lactose from milk, the E537D-β-Gal would
be immobilised to a solid support (magnetic nanoparticles (MNPs)), added
to the milk and allowed to bind some of the lactose present. This is possible
since the E537D mutated form of the enzyme allows for the formation of a
stable enzyme-substrate complex with an extended half-life. The MNPs, pro-
tein coated with the lactose bound in the active site, would subsequently be
manipulated to the side of the milk container through an external magnetic
eld and the milk with the reduced lactose content decanted.
1.3.1 Research question
The ultimate research aim was to develop a new sustainable technique for the
removal of lactose from milk that was also 1) aordable, 2) simple, 3) more
eective than the available techniques and 4) suitable for industrial application.
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1.3.2 Previous research on this project by our group
Amanda Dodd [4], a M.Sc Biochemistry student of Prof. Pieter Swart in
our laboratory at the department of Biochemistry, Stellenbosch University,
started with this project in 2009. She performed the cloning and site-directed
mutagenesis of β-Gal from Escherichia coli (E. coli) to produce a hexahistidine
(His6)-tagged E537D mutant of the enzyme of interest. After mutagenesis, the
wildtype and mutant β-Gal were kinetically characterized. The calculated
kinetic parameters for the wildtype β-Gal was a Km value of 0.22 mM and a
Vmax of 230 µmol/min/mg protein, for the E537D β-Gal these values were 0.27
mM and 2 µmol/min/mg protein, respectively [4]. The kinetic characterization
of E537D β-Gal indicated that the E537D mutation ensured the binding of the
substrate (lactose), but limited the hydrolysis to glucose and galactose as well
as the conversion to allolactose, which is an isomer of lactose and the natural
inducer of lac operon in E. coli [4].
Dodd went further and immobilised the wildtype and E537D β-Gal mutant
to Dynabeads (Invitrogen Dynal AS, Oslo, Norway, Cat. no. 101.03D) through
Immobilised Metal-Chelate Anity Chromatography (IMAC) by non-covalent
interactions between Co2+ on the nanobead surface and the His6-tag cloned on
the N-terminal of the protein/enzyme. The immobilised wildtype and E537D
β-Gal enzymes (45 µg protein per mg Dynabeads) were also characterized with
respect to their ability to bind, hydrolyze and extract lactose from a lactose
containing solution. Results obtained indicated that the mutant immobilised
through IMAC to Dynabeads was able to bind and remove approximately 15
% of 0.2 nmol lactose [4].
This study incorporated directed, IMAC, non-covalent interactions for the
coupling of β-Gal to MNPs. Directed coupling has advantages over random
strategies since the enzyme is orientated on the MNPs, which might improve
the accessibility of the active site to lactose. On the other hand, IMAC non-
covalent immobilisation is not ideal for implementation in industry due to the
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possibility of metal and enzyme leakage into the milk.
It is to prevent these possible leakages that this study incorporates covalent
coupling of β-Gal to MNPs. To accomplish covalent coupling, the particles
must be functionalized accordingly.
1.3.3 Goal of this study
Covalently immobilise puried E537D β-Gal through random immobilisation
strategies to commercially available MNPs and to subsequently test the ligand
binding ability of the formed complexes as well as the ability to remove lactose
from a lactose containing solution.
1.3.4 Objectives
To accomplish this goal, several objectives needed to be met, these were:
1. Verication and characterization of the cloned wildtype and E537D mutated
β-Gal enzyme.
2. Identication of accessible functional surface groups to be targeted dur-
ing covalent coupling to MNPs.
3. Covalent immobilisation of E537D β-Gal to commercially available MNPs.
4. Characterization of MNP-immobilised E537D β-Gal.
5. Upscale evaluation.
1.4 Experimental tasks
To ensure experimental progress and for documenting purposes the study was
divided into several experimental aims and tasks.
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1.4.1 Project controls: Characterization of Wildtype
and E537D β-Gal (Chapter 3)
 Aim 1: Characterization of β-Gal by repeating previous work done by
Dodd [4] to determine the reproducibility of results and to compare meth-
odologies.
The work described in the rst experimental chapter was necessary to re-
peat the expression of the cloned and mutated β-Gal enzyme as well as to
purify the enzyme through IMAC in order to obtain a pure sample for the
subsequent characterization and immobilisation purposes. Sucient controls
were included during all the steps to verify the presence of β-Gal and to elim-
inate contamination by other proteins. The kinetic parameters (Km and Vmax)
of the pure wildtype and mutant β-Gal were also determined in order to com-
pare a microtitre plate method [5] to the test-tube method previously used by
Dodd [4], as well as to verify and compare the activity of the pure wildtype
and mutant β-Gal.
1.4.2 β-Gal structure investigation (Chapter 4)
 Aim 2: Investigation and identication of the functional surface groups
of β-Gal accessible for covalent coupling to MNPs.
After the experimental characterization of β-Gal it was necessary to invest-
igate the three dimensional structure and surface topography of the protein to
determine the optimum functional group to be targeted during random cova-
lent immobilisation to MNPs. Two well-known molecular visualization tools
(DS ViewerProTM Version 5.0 and Yet Another Scientic Articial Reality
Application (YASARA)) were used to calculate and visualize the basic and
acidic amino acid content of β-Gal. This provided useful information in decid-
ing which of the functional groups should be targeted during the subsequent
covalent coupling step to limit enzyme structural changes and activity loss.
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1.4.3 A comparison between EDC and Glutaraldehyde
for random covalent immobilisation (Optimized)
of E537D β-Gal to commercially available surface
activated MNPs (uidMAG-Amine) (Chapter 5)
 Aim 3: Covalent immobilisation of β-Gal to MNPs as well as a com-
parison between the immobilisation potential of two dierent covalent
attachment strategies. The results would indicate which of the immob-
ilisation strategies employed were optimal regarding carrier capacity.
The three dimensional structure investigation revealed the optimum func-
tional surface groups to be targeted. This allowed the selection of the ap-
propriate commercially available MNPs as well as cross-linking agents to ac-
complish covalent immobilisation. E537D β-Gal was covalently immobilised
randomly to commercially available surface activated MNPs according to two
immobilisation strategies i.e. a coupling agent (N-(3-Dimethylaminopropyl)-
N'-ethylcarbodiimide hydrochloride (EDC)) and a cross-linking agent (glut-
araldehyde). The amount of protein (mg), temperature (oC) and absorption
time (min) were optimized for the two immobilisation strategies. The amount
of protein immobilised was estimated according to manufacturers instructions
for the Pierce bicinchoninic acid (BCA) protein assay kit that allowed for the
"colorimetric detection and quantication" of the total protein present in the
supernatant before and after immobilisation [6]. The covalent attachment was
also veried through several techniques.
1.4.4 Covalently immobilised E537D β-Gal activity
optimization and characterization (Chapter 6)
 Aim 4: Investigation and calculation of the retained activity and ligand
binding ability of E537D β-Gal after random, covalent immobilisation
Stellenbosch University  http://scholar.sun.ac.za
CHAPTER 1. INTRODUCTION 8
to MNPs through either EDC or glutaraldehyde cross-linking. This step
would indicate which of the random covalent coupling strategies of β-Gal
to MNPs was optimum in yielding a functionally immobilised enzyme.
The activity of the immobilised E537D β-Gal was investigated through β-
Gal enzymatic activity assays, with the use of o-nitrophenol-β-D-galactoside
(ONPG) as substrate [5]. The ligand binding ability of immobilised β-Gal
was investigated through radioactive binding studies using radioactive lactose,
otherwise referred to as D-glucose-1-14C, since it is only the glucose moiety of
the lactose that is labelled. The feasibility of the technique for possible indus-
trial application was tested by exposing the MNPs, with surface immobilised
E537D β-Gal, to a radiolabeled lactose solution and the subsequent quantic-
ation of the D-glucose-1-14C left in the solution after lactose extraction using
radioactive partition High Performance Liquid Chromatography (HPLC).
1.4.5 Upscale evaluation (Chapter 7)
Calculations regarding the possible upscaling of this novel technique for the
implementation thereof in the food processing industry was conducted and
evaluated.




The down-regulation of expression of the lactase enzyme in the small intestinal
villi of humans results in a common deciency known as lactose intolerant.
This lactase found in humans is the iso-enzyme of the β-Gal family of enzymes
present in a large variety of organisms that have important applications in a
variety of research elds [7; 8]. The main dierence between lactase and β-
Gal is the size. β-Gal is 464 kDa, while lactase is a mere 150 kDa. Not
only does β-Gal allow for the hydrolysis of lactose, but a signicant amount
of galacto-oligosaccharides (GOS) are also formed during lactose hydrolysis by
β-Gal with exceptional nutritional value in prebiotic foods [7]. Over 65 sources
of this particular enzyme provide researchers with a broad range of enzymatic
properties and structures that could ultimately be investigated individually [9].
β-Gal from E. coli is of particular importance to this study due to the well
understood nature and simplicity of working with this model organism. Several
important topics and techniques related to this study have been investigated
by numerous research groups. By referring to these related topics, as well as
highlighting the current health issue at hand, a better understanding of the
current research in this eld as well as a more elaborated proposal of how this
9
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project ts into the bigger scientic world is formulated.
2.2 Lactose intolerance
As previously discussed, lactose intolerance is a well known, common de-
ciency, which is characterized by the presence of inadequate amounts of the
lactase enzyme in the small intestine.
2.2.1 Prevalence
It is estimated that as much as 70 % of the world's population is lactase de-
cient and have diculty in consuming milk and dairy products [10]. According
to Madry et al. [11], lactase deciency is therefore the world's most common
enzyme deciency in humans.
Some speculation has raised the issue that it is possible for lactase de-
ciency to be the "natural" or "normal" state due to the wide variation in
prevalence (Table 2.1). Lloyd et al. [12] is of the opinion that it is possible
that an "abnormal" mutation occurred in the Northern European populations
allowing selective advantage to groups that consumes dairy products and there-
fore allowing signicant lactase activity well into adult life. However, there are
still many controversial views regarding this statement.
Table 2.1 summarizes the prevalence for lactose intolerance among dierent
ethnic backgrounds. It is interesting to note that both American Indians
and Asians have prevalence for primary lactase deciency of nearly 100 %.
These groups are identied by Simoons [2] as populations originating from
traditionally non-milking cultures who did not consume dairy products and
therefore did not develop a tolerance for lactose.
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Table 2.1: Prevalence of primary lactase deciency in various ethnic groups. As
summarized by Sahi in 1994 [3].
Group Prevalence (%)
Northern Europeans 2 to 15
American whites 6 to 22
Central Europeans 9 to 23
Indians
-Northern subcontinent 20 to 30
-Southern subcontinent 60 to 70
Hispanics 50 to 80
Ashkenazi Jews 60 to 80
Blacks 60 to 80
American Indians 80 to 100
Asians 95 to 100
2.2.2 Lactose biosynthesis
There are three enzymes that are closely related to the biosynthesis of lactose
(Figure 2.1) i.e. UDP-glucose pyrophosphorylase, UDP-galactose-4-epimerase
and lactose synthetase. UDP-glucose pyrophosphorylase and UDP-galactose-
4-epimerase together with phosphoglucomutase are responsible for the con-
version of glucose-6-phosphate to UDP-galactose, while glucose-6-phosphatase
converts a portion of glucose-6-phosphate to glucose. The synthesis of lactose
from these two monosaccharide sugars is catalyzed by lactose synthetase par-
tially regulated by α-lactalbumin (a milk protein).
Figure 2.1: Chemical structure of lactose, C12H22O11.
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This process, through which lactose is synthesized, is conned to female
mammals and occurs only in a single tissue, the mammary gland [13]. The
enzymatic reaction, through which lactose is synthesized, was rst conrmed
by Watkins and Hassid [14] and it was said to occur according to the following
reaction:
UDP − galactose+ glucose −→ lactose+ UDP
The complexity of the biochemical control mechanisms that appears to be
involved in the regulation of lactose biosynthesis was rst investigated in detail
by Palmitter in 1969. It was experimentally observed by Palmitter [15] that
the lactose content of milk varies inversely to the total fat and protein content
in milk but no apparent explanation was given for this phenomenon.
To conclude, α-Lactalbumin and the galactosyl transferase, the two com-
ponents of lactose synthetase, are suggested to play a critical role in the hor-
monal regulation of control mechanisms in lactose biosynthesis [13].
2.2.3 Lactose content of milk
The fat, fatty acid and protein content of milk can be changed/controlled over
a certain range but the lactose content is more or less stable [16]. The only
way in which the lactose content can be altered signicantly is through extreme
dietary manipulations [16]. Not only is lactose the major milk carbohydrate
in most species but, according to Squires [16], it is also the most important
osmotic component. It is therefore apparent that any changes in milk lactose
synthesis would be accompanied by changes in water volume and therefore
result in changes in milk yield.
Some animal species, like the kangaroo and bear, have very little lactose in
their milk while lactose contributes to up to 7 % of the total milk composition
of other species like humans and donkeys.
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The lactose content of several dairy products have been investigated by
many groups. Although there might be slight dierences between the calcu-
lated values, the general consent is that reduced fat (1 and 2 %) milk has a
higher lactose content (135 mmol/L) when compared to regular fat or raw milk
(130 mmol/L), but can vary from 111 - 155 mmol/L with the same variability
present in low fat yoghurts [17].
2.2.4 Lactose digestion
Lactase (EC.3.2.1.108), also known as lactase-phlorizin hydrolase (LCT), is
an enzyme located in the microvili of the small intestine enterocyte and is re-
sponsible for the cleaving/hydrolysis of the dietary disaccharide lactose into the
more absorbable monosaccharides, glucose and galactose, for the subsequent
transport across the plasma membrane (Figure 2.2) [11].
Figure 2.2: Lactase catalyzed lactose digestion. Lactose (C12H22O11) is hydrolyzed
(H2O) by lactase to yield Galactose (C6H12O6) and Glucose (C6H12O6).
2.2.5 Lactase deciency
The gastro-intestinal symptoms resulting from lactase deciency (hypolactasia
(HL)) in humans are summarized by Madry et al. [11] and Swagerty et al. [1]
as the result of decreased lactase activity in the small intestinal villi that
causes the unabsorbed disaccharide sugar, lactose, to accumulate, which in
turn results in the osmotic eect where more uid is attracted into the bowel
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lumen. Furthermore, this uid inux, caused by the high osmolality of the
sugars present, is accompanied by the production of gas through microora
fermentation of the bacteria-aected-unabsorbed-lactose that remains in the
colon. In addition, this gas results in the cleaving of lactose and the product,
monosaccharide sugars (glucose and galactose) further increase the osmotic
pressure in the bowel. Hence the net result of lactose ingestion by lactose
decient individuals is a considerable rise in uid and gas in the bowel [1; 11].
The three variations in lactase deciency can be described as primary, sec-
ondary and congenital. Primary lactase deciency refers to the most common
phenotype i.e. adult type hypolactasia [11] that occurs after weaning and con-
tinues throughout adult life. Here the expression levels of lactase in the small
intestine declines over time [1]. This has been hypothesized to be the "normal"
or "wildtype" state and that individuals prehistorically developed a tolerance
for lactose due to exposure to it [2]. Secondary or acquired lactase deciency
is as a result of any of a range of gastrointestinal illnesses. Lastly, congenital
lactase deciency is rare and is characterized by a complete lifelong absence of
lactase [1].
2.2.6 Symptoms and current solutions
Suerers of lactase deciency are unable to digest signicant amounts of lactose
and may develop certain clinical symptoms such as atulence, blanching,
cramps, abdominal pain and distention, and loose, watery stools following
the indigestion of lactose containing food products [1; 10]. The only direct
measurement of lactase, to diagnose lactase decient patients, requires a small
intestine biopsy; patients usually decline this procedure due to its invasive
nature [11]. Other diagnostic tests include the analysis of blood glucose levels
or breath hydrogen levels after the ingestion of a predetermined dose of lactose
(1 to 1.5 g lactose per kg body weight) [1]. The blood glucose test is directed
at measuring the carbohydrate metabolism while the hydrogen breath test is
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directed towards measuring the production of hydrogen and other gasses in
the colon [1].
Currently the solution to, or treatment of, lactase deciency is simple diet-
ary adjustments. For some this may be a solution but for those that suer from
congenital lactase deciency this is not ideal. Apart from lactose, milk and
dairy products contain other essential nutrients like calcium. Dairy products
provide an astounding 75 % of the calcium that is available through food sup-
ply. Without this natural calcium resource, adult patients should maintain
a daily calcium intake of 1200 to 1500 mg, which would in this case require
the taking of daily supplements [1]. Other temporary treatments include the
taking of commercially available lactase enzyme supplements like Dairy Ease,
Equate and Lacteeze lactase products.
Some lactose free or lactose reduced dairy products are currently available
on the market but these products are produced through the hydrolysis of the
lactose present in milk and not the actual removal of the lactose. It follows that
these products then have a signicantly sweeter taste than normal lactose con-
taining milk products since these lactose free products now contain two moles
of sugar (glucose and galactose) instead of only one mole (lactose). Further-
more, the relative sweetness of these sugars, when compared, also indicates
that glucose and galactose are both signicantly sweeter than lactose [18].
All the current treatments for lactose intolerance as well as commercially
available lactose free products involve the lactase enzyme. This can be either
directly as dietary supplements or indirectly as part of the manufacturing
process for the production of these lactose free products. It would thus be
benecial to this study to investigate this enzyme (β-Gal) and to determine
which of its characteristics can be manipulated to contribute to the success of
this project.
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2.3 β-Galactosidase
β-Gal (EC.3.2.1.23) is the hydrolase enzyme of interest for this study and also
known in biochemistry as a retaining glycosidase. This means that the enzyme,
β-Gal, catalyzes the conversion of lactose to allolactose as well as the hydrolysis
of lactose into glucose and galactose through a double displacement reaction
where the product and starting states have the same stereochemistry [19]. β-
Gal is dependent on mono- and divalent cations for full activity and the most
common cations used for kinetic assays are sodium, potassium, magnesium
and manganese [19].
The enzyme can also be used in transglycosylation of lactose to synthesize
GOS which is a prebiotic used in many food products [9]. Figure 2.3 is a
schematic to explain this function of β-Gal [20]. β-Gal has also been obtained
and/or isolated from a wide variety of sources, such as plants, animals and
microorganisms, including bacteria, fungi and yeast. It is also general practice
to refer to β-Gal as lactase and vice versa since lactase is an iso-enzyme of
β-Gal.
Figure 2.3: Transglycosylation of lactose to produce GOS, as shown for the example
galactosyllactose.
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2.3.1 Sources
Although β-Gal can be obtained from a variety of sources, their kinetic, chem-
ical and reaction properties dier noticeably [21]. Microbial sources have some
denite advantages over enzymes of plant and animal origin, since microorgan-
isms are easier to handle, have a higher multiplication rate and produces high
yields [9]. Currently there is a considerable amount of known β-Gal sources
including species from 23 bacterial genera, 11 fungi genera and 4 yeast genera.
Table 2.2 and Table 2.3, as summarized by Panesar et al. in 2010, includes
all the known microbial sources of β-Gal. For the purpose of this study, only
β-Gal from E. coli will be discussed in greater detail.
2.3.2 Structure of β-Gal from Escherichia coli
β-Gal (Figure 2.4) from E. coli is a large homotetramer with a total molecular
weight of 464 kDa. Each subunit consists of 1023 amino acids and is 116 kDa
in molecular weight. It is composed of 5 domains and the active site is a deep
pocket with identied mono- and divalent cation binding sites [22]. This deep
pocket of the active site is built around the central (α/β)8 barrel where other
domains are also recruited to this area to bestow specicity for the disaccharide
substrate [23]. Some details regarding the enzyme-substrate interactions of β-
Gal and lactose have been investigated previously. There are three main amino
acid residues that are said to be located to the active site i.e. Glu461, Met502
and Glu537 (Shown in Figure 2.5) [19]. These, and other active site residues,
have been studied regarding their specic roles and interactions with substrate
hydroxyls. Following this, it was suggested that Glu461 may act as a proton
donor while Glu537 is the nucleophile [2426]. Glu537 is then also the amino
acid residue that was targeted during site directed mutagenesis by Dodd [4]
to yield E537D β-Gal. It is, however, unfortunate that the large size of β-Gal
has limited detailed investigations into structural information regarding β-Gal
ligand binding [19].
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Figure 2.4: Three dimensional structure of the β-Gal enzyme. Secondary structure
representation of the homotetramer in which each subunit is shown in a dierent
colour. The gure was created using DS ViewerProTM Version 5.0.
Figure 2.5: Three dimensional secondary structure representation of the active
site of one of the subunits of β-Gal. Orientation of the amino acid residues located
to a single active site are indicated in dierent colours i.e. Glu461 (Red), Met502
(Yellow) and Glu537 (Blue). The gure was created using DS ViewerProTM Version
5.0.
2.3.3 Applications of β-Gal
The enzymatic hydrolysis of lactose to the product monosaccharide sugars
oers several benets in three main areas i.e. health, environment and food
technology. The hydrolysis of lactose can be carried out either by enzymatic
catalysis with β-Gal that allows for milder pH and temperature operating
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conditions or by acid treatment at more extreme conditions (150 oC) [27].
2.3.3.1 Health
As discussed previously, almost 70 % of the world's population has an inab-
ility to digest signicant amounts of dietary lactose, also known as lactose
intolerance. This well known lactase enzyme deciency limits individuals with
regards to the intake of dairy products, since consuming such dairy products
will lead to mild discomfort. Sieber et al. [28] stated that by hydrolyzing
the lactose with β-Gal to the more readily utilizable monosaccharide sugars,
glucose and galactose, this problem of lactase deciency could be circumvented
[28]. This is then also currently the main application for β-Gal in the health
industry.
During the enzymatic hydrolysis of lactose, GOS are formed at the same
time. GOS are used as ingredients in prebiotic food and these compounds are
indigestible, acting as dietary bre [7]. GOS promote intestinal bidobacteria
growth, ensuring a healthy environment in the intestine and the liver [7]. By
developing an inexpensive and eective GOS manufacturing process through
the implementation of β-Gal, this enzyme can satisfy the growing demand for
GOS production.
2.3.3.2 Environment
The dairy industry produces abundant amounts of a byproduct called whey
containing large amounts of lactose and protein [8]. This waste can cause
several environmental and economical issues if it is not disposed of properly.
Problems arise especially due to the high chemical and biochemical oxygen
demand, which lactose is associated with [8]. Guimaraes et al. [8] is of opinion
that by implementing β-Gal in the hydrolysis of the lactose present in whey,
the whey can be converted into a very useful product, sweet syrup, that can
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be used in the confectionary, soft drink, dairy and baking industries thereby
limiting its negative impact on the environment. Whey lactose can also be
degraded by β-Gal for GOS manufacturing purposes.
2.3.3.3 Food Technology
Excessive lactose crystallization is a common occurrence in milk products that
have high lactose content, such as frozen milks, condensed milk, whey spreads
and ice-cream [7]. This usually results in a unpleasant gritty, sandy or mealy
texture. According to Grosova et al., β-Gal can be used to prevent this side-
eect by processing such products to reduce the lactose concentrations to more
acceptable values and by doing so, improve the sensorial and technological
quality of these dairy foods.
Many of the above mentioned applications for β-Gal prevents the use of
the free, unimmobilised form, due to the inability to eectively remove this
still active enzyme from the product without turning to time-consuming meth-
ods. On the other hand, immobilised β-Gal, whether it is to glassplates [29],
cellulose beads [30] or bers [31], are readily manipulated and as a result, relat-
ively simple to remove from crude mixtures. Strategies for the immobilisation
of proteins are endless and since the covalent immobilisation of β-Gal forms
part of this project, a detailed investigation into these strategies is necessary.
2.4 Protein Immobilisation
According to Rao et al. [32], the immobilisation of proteins in general has
been performed successfully on packed beads, hollow ber modules, magnetic
nanoparticles, in hydrogels and on suspended particles. These immobilisa-
tion procedures can include physical or chemical adsorption of the protein to
the solid support surface as well as random or site-specic orientation of the
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immobilised protein.
Protein immobilisation is very attractive, especially for enzymatic studies,
due to the proposed enhanced stability of the protein of interest as well as the
extended range of applications the protein can now be used for. According
to Panesar et al. [9], β-Gal may have numerous applications in the food and
dairy industries, but currently the marginal stability of the enzyme hinders
the general industrial implementation of this biocatalyst on a larger scale. β-
Gal enzyme stabilization via immobilisation to solid supports and a variety
of cross-linking strategies to ensure optimum subunit-subunit interactions as
well as a stable multimeric form of the enzyme have been investigated by
several research groups [33; 34]. The idea behind this strategy is to determine
the proper experimental conditions to yield an active and stable immobilised
enzyme for potential implementation as a biocatalyst in the food technology
industry [33; 34]. Table 2.4 [2931; 3556] is a summary of all the dierent
methods that have been investigated for the immobilisation of β-Gal compiled
by Grosov'a et al. [7]. The percentage activity recovered for the specic
method is also annotated.
The highest percentage of activity recovered (90 %) were achieved via co-
valent binding to porous silanised glass via glutaraldehyde cross-linking [29],
while the carbodiimide coupling of β-Gal to alginate beads also resulted in
a relatively high percentage activity recovered (76 %) [46]. Interestingly, the
physical adsorption methods, thought to be less harsh than covalent binding
methods, did not necessarily result in a higher percentage recovery of activity
(Table 2.4).
2.4.1 Physical adsorption
This very simple enzyme immobilisation method is established through phys-
ical forces (Van der Waals forces) that occur between the biocatalyst and the
surface of the water-soluble carrier. Other forces can be involved in the interac-
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tion between the biocatalyst and the carrier i.e. hydrogen bridges, heteropolar
(ionic) bonds and hydrophobic interactions [57].
The simplicity of this method for biocatalyst immobilisation as well as
the small inuence it has on the biocatalyst conformation contributes to the
main advantages of physical adsorption, especially for enzyme immobilisation
[9]. It has, however, been shown that the simple process of physical adsorp-
tion immobilisation has some major drawbacks i.e. random attachment, relat-
ively weak adsorptive binding forces between the carrier and the biocatalyst,
decrease of immunological capture eciency, protein denaturation, molecule
accessibility problems as well as the occurrence of overlapping [58].
As summarized by Panesar et al. [9], several organic (starch, cellulose, ion-
exchange resins and activated carbon) and inorganic (silica, alumina, ceramics,
porous glass, clay, diatomaceous earth, bentonite, etc.) support materials can
be used for the physical adsorption of enzymes. Refer to Table 2.4 for previous
solid supports used in β-Gal physical adsorption strategies accompanied by the
percentage activity retained, which provides a measure of the success of the
method.
2.4.1.1 Immobilised metal-chelate anity chromatography
(IMAC) enzyme immobilisation
IMAC is a commonly known technique for the purication of proteins fuzed
to poly-histidine (His) tags. In some cases the adsorption of this poly His-tag
to the chelate support is quite strong and may further suce as a medium for
enzyme immobilisation. IMAC can therefore be seen as a physical adsorption
technique for the immobilisation of poly-His tagged proteins.
As previously mentioned, physical adsorption has some drawbacks. The
main drawbacks of IMAC include the reversibility of the binding process as
well as the possible undesired release of metals to the reaction media [59].
These may become a problem when the immobilised protein complexes are
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used for industrial purposes.
This is the method of immobilisation that Dodd [4] used. Due to the
possible industrial implementation of this novel technique, the IMAC physical
adsorption of β-Gal to the MNP surface is not preferred due to possible enzyme
and metal leakages. To prevent these leakages form occurring, this study
focusses on the covalent immobilisation of β-Gal to MNPs, which would ensure
a strong, permanent bond between the protein of interest and the MNP surface.
2.4.2 Entrapment method
Entrapment can be easily explained as the enclosure of enzymes or molecules
in a small space. The major methods of entrapment are membrane (including
microcapsulation) and matrix entrapment [9].
According to Panesar et al. [9], the simplicity, especially when referring
to the method to obtain spherical particles, is possibly the major advantage
of this technique. Furthermore, the transparency and general mechanical sta-
bility of such beads formed from alginate may be advantageous in enzyme
immobilisation studies [9]. The major drawback of this enzyme immobilisa-
tion technique is the potential slow leakage of enzyme during continuous use
[9]. Certain improvements can, however, be made by means of appropriate
linking procedures.
Some of the membranes that are commonly used for enzyme immobilisa-
tion through entrapment are cellulose, nylon, polyacrylamide and polysulfone
as mentioned by Panesar et al.. Matrices on the other hand can consist of
more polymeric materials such as agar, Ca-alginate, k -carragenin, collagen and
polyacrylamide or even some solid matrices such as porous ceramic, activated
carbon and diatomaceous earth [9].
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2.4.3 Cross-linking
Cross-linking, used on its own or in combination with other immobilisation
techniques, such as entrapment and adsorption, is a well-known method for
biocatalyst, protein and peptide immobilisation to either other protein mo-
lecules or to functional groups on insoluble carrier/support materials [60].
Cross-linking can be via ionic or covalent bonds resulting in physical or ox-
idative cross-links. Cross-linking reagents have reactive ends to specic func-
tional groups i.e. sulfhydryls, primary amines, etc [60]. The reactions can
include cross-linking compounds that are bi-functional (homo- or hetero-bi-
functional) or even multi-functional. Some examples of reactive cross-linker
groups with their functional group targets are: hydrazide (carbohydrate), im-
idoester (amine), carbodiimide (amine/carboxyl), isocyanate (hydroxyl), car-
bonyl (hydrazine), maleimide (sulfhydryl), NHS-ester (amine), vinyl sulfone
(sulfhydryl, amine, hydroxyl), PFP-ester (amine) and hydroxymethyl phos-
phine (amine) [60].
2.4.4 Covalent enzyme immobilisation
A covalent bond is dened as a chemical link between two atoms in which elec-
trons are shared between them. Some amino acid groups can take part in co-
valent immobilisation i.e. ε-amino of lysine and N-terminal amino group, sulf-
hydryl of cysteine, carboxyl group of aspartate and glutamate and C-terminus
carboxyl group, phenolic of tyrosine and imidazole of histidine [32]. A wide
range of attachment methods exist. These, with their accompanying reactive
amino acid groups, are summarized in Table 2.5.
According to Teste et al., covalent anchoring of biomolecules enable stronger
and more reproducible attachment to solid supports compared to randomized
or physical adsorption [58]. Additionally, covalent immobilisation can produce
molecules arranged in a dened, orderly fashion and also allows the possible
use of linkers and spacers to help minimize steric hindrances that can occur
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Table 2.5: Amino acids involved in covalent immobilisation, and method of attach-
ment as summarized by Rao et al. in 1998 [32].
Amino acid Reactive Method of attachment
residue
ε-amino group of lysine -NH2 Diazotization





Sulfhydryl of cysteine -SH Alkylation
Thio-disulde interchange
Mercury enzyme interaction




Phenolic of tyrosine Diazotization
Imidazole of histidine Diazotization
between the protein and immobilisation surface [61]. This is advantageous,
since biomolecule-solid support complexes and conjugates are used in analyt-
ical, clinical, environmental, biomedical and industrial chemistry where the
procedures require the permanent or semi-permanent immobilisation of func-
tional biomolecules.
Apart from forming strong linkages between the protein and the solid sup-
port, covalent immobilisation can potentially result in changes in the structural
conguration of the immobilised protein. This is, according to Camarero [61],
"mainly due to the heterogeneous chemical nature of proteins as well as the
marginal stability of the native, active tertiary structure over the denatured,
and inactive random coil structure". In the case of enzymes, such a struc-
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tural change can lead to inaccessibility of the active site, reduced activity or
even altered reaction pathways [32]. It is noteworthy that all of these can be
avoided through an in-depth study of the primary and secondary structure of
the protein of interest.
Gauthier and Klok [62] is of opinion that, for an enzyme to be functionally
immobilised covalently to a solid support, the amino acid residues targeted
have to be reasonably exposed on the surface of the protein of interest and
accessible. This requires an investigation into the tertiary structure of the
protein as well as information regarding the average surface accessibility of
these targeted amino acid residues [62]. Camarero [61] feels that it is also
important to consider that the immobilisation reaction should be able to occur
eciently under physiological conditions to avoid protein denaturation during
the coupling step.
Covalent protein immobilisation is usually achieved through two steps i.e.
surface activation and biomolecule immobilisation (adsorption through an in-
cubation step) [58]. Furthermore, to achieve site-specic protein immobilisa-
tion, two unique and mutually reactive groups are required on both the solid
support and protein surface [61]. To conclude, covalent immobilisation can
produce a permanent and reproducible active immobilised enzyme with the
active site still accessible to the substrate and where steric hindrance is lim-
ited to a minimum through the use of a linker.
There exists a wide range of solid supports for the immobilisation of pro-
teins. The selection of a specic solid support relies on the functionality and
separation properties of the support as well as the nal application of the im-
mobilised protein. As part of this project, the immobilisation of a protein to
magnetic nanoparticles, it would be benecial to elaborate on this aforemen-
tioned solid support.
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2.5 Magnetic nanoparticles (MNPs)
Nanoparticles, and other nanomaterials, have recently turned into a popular
topic with regards to biotechnological and other scientic applications where
the immobilisation of dierent biomolecules to these materials has been demon-
strated [63]. Proteins that are conjugated to these nanoparticles can be used
for the studying of protein-protein interactions, screening of combinatorial lib-
raries, drug delivery, and enzyme immobilisation for polysaccharide hydrolysis
[63]. According to Tartaj et al. [64], these nanoparticles with dimensions
between molecules and micro-sized structures are small enough that they have
unique properties but are suciently large that they provide access to realms
of quantum behaviour.
According to Tartaj et al. [64], there are four advantages in using particles
with a size smaller than 100 nm:
 higher eective surface areas
 improved tissular diusion
 lower sedimentation rates
 reduced magnetic dipole-dipole interactions.
MNPs, as compared to just nanoparticles, are particles with strong mag-
netic properties. These have become particularly useful, rstly because of the
capability of magnetic targeting (positioning to a specic area) and secondly
because they are readily manipulated, controlled and recovered for reuse by
an external magnetic eld. Some of the unique characteristics of MNPs are
high eld irreversibility and superparamagnetism [64]. Potential applications
of MNPs include biomedicine [65] where superparamagnetic behaviour is ne-
cessary at room temperature, data storage [66] where the particles need to have
a switchable, stable magnetic state, catalysis [67], magnetic particle imaging
[68], magnetic resonance imaging [69] and environmental remediation [70].
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2.5.1 Magnetic core material
Depending on the in vivo or in vitro application of the MNPs, several factors
need to be taken into consideration when choosing the magnetically respons-
ive component. These factors include the toxicity, magnetic properties, nal
particle size as well as the biocompatibility of the material considered for the
particle core [64]. For the in vivo application of these particles, a biocom-
patible polymer coating is also necessary to prevent changes from the original
structure, formation of aggregates and biodegradation [64].
According to Tartaj et al. [64], some common materials used for the
magnetic component are iron, magnetite, cobalt, nickel, samarium-cobalt and
neodimium-iron-boron. The iron oxides, magnetite (Fe3O4) or its oxidized
form maghemite (Fe2O3), are the most commonly employed material to pro-
duce MNPs, especially for biological and biomedical applications. These mag-
netite MNPs are easy to synthesize, have strong magnetic properties [71] and
exhibit low toxicity [72], which will facilitate future application in the food
process industry. In contrast to this, cobalt and nickel, that also has high
magnetic properties, are toxic and susceptible to oxidation and not often used
for MNP synthesis [64].
2.5.2 Synthesis of MNPs
The ultimate synthesis/preparation method for these particles are those that
allow the synthesis of particles that are nearly uniform in size and shape. Fig-
ure 2.6 is a ow diagram that summarises all the synthesis methods for MNPs
[64]. The simplest of these is the coprecipitation method to yield magnetite
particles and this is the only method that will be discussed here in detail.
Magnetite nanoparticle synthesis can occur through a coprecipitation reac-
tion where magnetite (Fe3O4) particles form spontaneously when an aqueous
solution of ferrous (Fe2+) and ferric (Fe3+) ions is mixed with a strong base
like NH4OH/NaOH at room temperature. It has, however, been shown that to
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Figure 2.6: Flow diagram explaining the dierent precipitation and aerosol methods
for the synthesis of MNPs [64].
narrow the size distribution to yield uniform physical and chemical properties
is not an easy task [73]. Dierent techniques to optimize dierent properties
of magnetite nanoparticles exist but most of these are rather conicting.
Zhu and Wu [74] proposed that they could produce nanoparticle synthesis
results with an average particle size less than 6.0 nm by applying forced mix-
ing without any surfactants. Sun and Zeng [73] on the other hand stated that
they can control the size of magnetite nanoparticles (3 to 20 nm) produced
through simple organic phase synthesis. Both of these research groups com-
pleted the synthesis under nitrogen and at elevated temperatures. Yazdani and
Edrissi [75] studied the eect of pressure on the size of produced nanoparticles
and found that it had a signicant eect. They found that when increasing
the pressure of the nanoparticle synthesis reaction from 300 to 6000 mbar,
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the obtained particle size increases from 8.3 to 16.8 nm at room temperature
(25oC) [75]. They attributed this phenomenon to physical property changes
regarding the nanoparticles' large surface-to-volume ratio [75]. Liu et al. [76]
employed high temperatures, stirring of the reaction mixture and a nitrogen
atmosphere for nanoparticle synthesis. However, they used a surfactant (oleic
acid) to form a waterproof shell around the magnetite nanoparticles. They
report a simple yet ecient method to prepare Fe3O4 nanoparticles as a mag-
netic gel that has super paramagnetic properties at room temperature. The
same authors also claim that these hydrophobic gels could facilitate the incor-
poration of magnetite nanoparticles in polymer matrixes through hydrophobic
interactions between the compounds [76].
To conclude, it seems as though thermal treatment, synthesis under ni-
trogen as well as surfactant coating of the magnetite nanoparticles yields a
superparamagnetic, concentrated hydrophobic gel that may perhaps be ex-
tremely versatile regarding surface functionalizations; especially with regards
to polymer matrix coatings [76].
2.5.2.1 Properties of magnetite MNPs [77]
Magnetite is a black, ferromagnetic mineral at room temperature and has
a Curie temperature of 850 K containing both divalent (Fe2+) and trivalent
(Fe3+) iron. Magnetite has an inverse spinel structure and a cubic crystal
system.
The surface area of magnetite ranges from 10 m2g−1 for Fe3O4 formed by
reduction of haematite to close to 100 m2g−1 for particles ca. 50 nm across
produced by precipitation. In 1966 Mannweiler [78] used three dierent meth-
ods to determine the surface area of a sample of cubic magnetite crystals (194
nm across) that was obtained by the reduction of haematite. These were X-
Ray diraction line broadening, Transmission Electron Microscopy (TEM) and
BET (N2) measurement. The resulting areas obtained by all three methods
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were in very good agreement - 5.66.6 m2g−1.
In general magnetite has a very high surface to volume ratio, which makes
it ideal for surface chemistry modications.
For the nal implementation of our novel technique in the food processing
industry, we need to consider dierent bioreactors that might facilitate the
application of our MNP immobilised β-Gal enzyme.
2.6 Bioreactors
There are three general bioreactor systems, the dierence depending on the
method of biocatalyst immobilisation and the type of process required. These
are Fluidised bed reactor (FBR), Packed bed reactor (PBR) and Membrane
reactor (MR).
2.6.1 Fluidised bed reactor (FBR)
In this type of bed reactor the immobilised enzyme particles are uidised,
which means that the ow of the substrate stream causes the particles to
become suspended in the substrate stream. If their density is suciently high
the immobilised enzyme particles are quite small, ranging from 20 to 40 µm
in diameter [79].
The main advantage of FBR over PBR is that pretreatment of the feed is
not necessary before the use. However, FBR is usually quite dicult to scale
up and its use is commonly restricted to smaller scale but high priced products
[79; 80].
2.6.2 Packed bed reactor (PBR)
This bioreactor system is the most popular for the enzymatic hydrolysis of
lactose [81]. In this type of system a column is packed with the immobil-
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ised enzyme particles and the accompanying substrate is pumped through the
column in plug ow direction [7]. This plug ow is dened as the constant
velocity of ow in every part of the system and this type of reactor improves
contact between the two phases, liquid and stationary. The matrix used is
normally fairly rigid with the diameter of the pellets about 13 mm.
An advantage of the PBR is that it permits the use of high density biocata-
lysts and therefore results in high volumetric eciencies. These type of reactors
are also preferred in enzymatic reactions involving product inhibition, e.g. the
enzymatic hydrolysis of lactose.
The limitation of the PBR is that it does not allow for the monitoring
and regulation of pH and temperature in reactors with a >15 cm diameter.
According to Lilly and Dunnill [82], it is more advantageous to have a uniform
pellet size and an upward substrate stream ow.
2.6.3 Membrane reactor (MR)
A MR system consists of a membrane (e.g. dialysis membrane) that is im-
mersed into a stirred tank. The membrane contains the enzyme of interest,
generally in a free form, within an inner chamber where the substrate is al-
lowed to freely move in and the product of the enzymatic reaction, allowed to
move out [7].
This reactor allows for continues operation with high enzyme concentration
and low pressure [7]. It has, however, been shown that the enzyme in a MR
has less stability than the PBR enzyme due to wash out eects. There is also
a continuous need for membrane replacement and a limitation to the diusion
of substrate and products through the membrane [83].
Of these three general bioreactor systems, PBR are the most often used for
lactose hydrolysis. The use of MNPs in this study may require the development
of a bioreactor where several incubation periods of the same batch of milk with
the protein coated particles could be used to remove the desired amount of
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lactose under controlled conditions.
2.7 Conclusion
β-Gal from E. coli was used in this study since E. coli is a well character-
ised organism and easier to work with as compared to human lactase. Due to
the biotechnological advances and applications in industrial processes and bio-
medicine, MNPs was chosen as the desired solid support simply because of the
capability of magnetic targeting, surface modications and its simplicity. The
covalent strategy for the coupling of β-Gal to MNPs is mainly to prevent en-
zyme leakage, which can readily occur with physical adsorption, non-covalent,
enzyme coupling.
For the ultimate bioreactor application of the immobilised enzyme-particle
complex, a functional and covalently linked β-Gal MNP compound needs to be
assembled. To achieve this, a pure form of the enzyme as well as functionalized
MNPs are necessary.
During the subsequent chapters, the individual aims of this project are
investigated and discussed to ultimately explain the properties and possible
industrial implementation of this novel technique to enhance current practice
in producing lactose free dairy products.






In order to achieve the main objective of this study, the covalent immobilisation
of β-Gal to commercially available MNPs for the possible application of binding
lactose and physically removing this from milk, functional β-Gal had to be
obtained. Functional β-Gal from E. coli was previously cloned and successfully
puried by Dodd [4]. It was, however, necessary to repeat and verify some of
this previous work regarding the β-Gal mutagenesis, expression, purication
and activity to conrm the reproducibility of the results as well as to compare
dierent strategies for β-Gal enzymatic activity determination. Here, results
of a microtitre plate assay was compared to the results previously obtained by
Dodd with a test tube assay. This was necessary since the new microtitre plate
assay [5] limits the inuence of human error and therefore provides better and
faster control over the assay conditions.
By going through these steps to obtain the pure and active wildtype and
37
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E537D His6-β-Gal, the signicantly lower enzymatic activity of the pure mutant
β-Gal would be veried that would theoretically allow for the removal of lactose
from milk when immobilised to MNPs with minimal hydrolysis to glucose and
galactose (refer to section 1.3). In addition to this, the pure mutant β-Gal
obtained would be utilized in the succeeding immobilisation approaches.
The cloning and mutagenesis of the LacZ gene was previously performed
by Dodd [4]. The Gram negative bacterium, Escherichia coli, was used in
this study as the model organism for the heterologous production of β-Gal.
According to Baneyx [84], E. coli is one of the most attractive systems for
the production of heterologous proteins due to the well characterized nature
of its genetics, availability of a whole range of cloning vectors and its ability
to grow rapidly and at high density on inexpensive substrates. Furthermore,
growing of cultures and inducing heterologous protein expression with E. coli
as the host is relatively straight forward, resulting in sucient protein yields for
protein purication and subsequent analyses. Although E. coli is not generally
regarded as safe, especially not in the food process industry, it is an ideal model
organism to form part of this proof of concept study.
In order to characterize any protein, a pure fraction is needed. Protein
purication is generally directed at exploiting protein characteristics like size,
isoelectric point, structure or biological activity to isolate a specic single type
protein from a mixture or crude extract of proteins for subsequent use. Puric-
ation methods include a range of chromatographic methods like ion-exchange,
size exclusion, anity and high performance chromatography. Heterologous
expression of recombinant proteins, however, allows for the inclusion of a his-
tidine tag to the N- or C-terminal of the required protein. This modication
of the primary structure of the protein yields an active protein that can be
readily isolated by IMAC.
IMAC was rst introduced in 1975 and is directed at exploiting the chemical
anity that exists between solute molecules and immobilized metal ions [85].
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The concept of IMAC can be explained as metal-ions (Cu2+, Zn2+, Ni2+, Co2+
and Fe2+) localized in an exposed position in an insoluble polymer matrix (eg.
carboxylic-sulfonic, or sulfate ester-type cation exchangers) that has anity
for certain analytes or ligated tags on the N- or C-terminal of the protein of
interest in the sample to be fractionated [85]. IMAC is widely used for the
purication of poly-histidine tagged proteins since these poly-histidine tags can
readily interact with immobilised transition metals and separate these tagged
proteins from other proteins present in the crude extract by means of gradient
elution. According to Porath [85], some of the main advantages of IMAC are
the mild and non-denaturing conditions it allows for the isolation of a specic
protein of interest on a milligram or gram scale. IMAC consists primarily of
ve consecutive operations i.e. column equilibration, sample injection, removal
of non-specic bound fraction, elution of protein of interest and regeneration
[85]. Due to the His6-tag cloned on the N-terminal of the wildtype and mutated
versions of β-Gal [4], an IMAC purication strategy was used to obtain pure
protein for experiments carried out in this study.
After the isolation of the protein of interest, protein characterization is ne-
cessary. The kinetic parameters of β-Gal from E. coli have been investigated
by several research groups using various substrates, such as: o-nitrophenyl-β-
D-galactopyranoside (ONPG), 4-nitrophenyl β-D-galactopyranoside (PNPG),
allolactose and alpha-lactose, reaction temperatures, incubation volumes, buf-
fer compositions and the wavelengths at which the absorbencies of the reaction
products were measured. ONPG was most commonly used as substrate with
the reaction temperature varying between 25 oC [5], 30 oC [BRENDA data-
base (BRaunschweig ENzyme DAtabase)(EC 3.2.1.23)] and 37 oC [86], while
the reaction was performed in test tubes (3 ml; [86]) or microtest plates (200
µl; [5]) and monitored at 410 nm [86] or 420 nm [5].
Yuan et al. [87] investigated the eect on enzymatic activity of several
mutations of the glutamic acid (E) in position 537, a residue that was also
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targeted by Dodd [4]. When this glutamic acid was mutated to an aspartic
acid (D), a 760 fold decrease in activity was found. Mutation to a glutamine,
however, resulted in a 160 000 fold decrease in activity while a valine in posi-
tion 537, instead of the glutamic acid, caused a 28 000 fold decrease in activity
with ONPG as substrate at 25 oC [87]. The accompanying, calculated Km val-
ues for the individual point mutations were found to be similar to that of the
wildtype enzyme except for the E537D mutation, where a slightly higher sub-
strate concentration was required to reach half maximal velocity [87]. For the
purpose of this study, the ideal would be a mutated enzyme with signicantly
less activity when compared to the wildtype enzyme, but one that still oers
both the very slow hydrolysis of lactose, to compensate for the possible loss
in sugar content, as well as sucient substrate binding to enable the binding
and removal of lactose from milk. The point mutation of E537D was therefore
selected for the purpose of this study [4].
According to a consumer sensory test, conducted by Adhikari et al. [18],
commercially available lactose-free milk is sweeter, contains more cooked and
processed avours and has a higher viscosity and a chalkiness when compared
to normal low fat milk. The sweeter taste of lactose-free milk results from the
relative sweetness of glucose and galactose (hydrolyzed lactose) compared to
lactose itself. The use of the E537D mutant β-Gal would, therefore, theoretic-
ally allow the removal of a percentage of the lactose present in milk, whereafter
only the residual lactose would be hydrolyzed to glucose and galactose, by us-
ing the immobilised wildtype β-Gal, instead of all the lactose, as is current
practice [18]. This will limit the ultimate sweetness of the nal lactose free
milk and possibly improve the sensory quality.
Stellenbosch University  http://scholar.sun.ac.za
CHAPTER 3. PROJECT CONTROLS: β-GALACTOSIDASE
CHARACTERIZATION 41
3.2 Materials and Methods
3.2.1 Reagents and chemicals
The plasmid vector pTrcHis-LacZ and mutagenesis product, pTrcHis-LacZ_E537D,
were obtained from previous studies in this laboratory. A bicinchoninic acid
(BCATM) protein assay kit was purchased from Thermo Scientic (Rockford,
USA) and microplates for protein determination assays from Heinz Herenz
Hamburg (Germany). Precision Plus Protein KaleidoscopeTM markers for
SDS PAGE and immunoblotting were purchased from Bio-Rad Laboratories,
Inc. (Hercules, USA). Anti-β-galactosidase primary antibody, as a rabbit IgG
fraction, was purchased from Invitrogen (USA), while Alkaline Phosphatase
conjugated secondary anti-rabbit IgG, produced in goat, and sample buer
according to Lämmli (2X) were purchased from Sigma-Aldrich Chemical Co.
(Germany). HisProbeTM -HRP as well as Pierce ECL Western Blotting sub-
strate were purchased from Thermo scientic. HiTrapTM (1 ml and 5 ml)
chelating columns (Amersham Biosciences) and Spectra/Por Dialysis Mem-
brane with Mw cut o: 6-8000 (Spectrum Laboratories, Inc.) were obtained
from a local supply house. 2-nitrophenyl-β-D-galactopyranoside (ONPG) was
obtained from Sigma-Aldrich Chemical Co. (Germany). All chemicals used for
the preparation of buers and solutions were of analytical grade or higher and
purchased from Merck (Pty) Ltd (South Africa), Sigma-Aldrich Chemical Co.
(Germany) or Bio-Rad Laboratories (Pty) Ltd (South Africa). An Ultra Pure
Milli-Q water system (Millipore (South Africa)) was used to produce reagent
grade water used in all buers and experiments.
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3.2.2 Wildtype and E537D β-Gal expression and
verication
3.2.2.1 Protein expression
Starter cultures (SC) were prepared from pTrcHis-LacZ and pTrcHis-LacZ_E537D
E. coli Top 10 freezer stocks by inoculating 5 ml Luria-Bertani (LB) media
containing 50 ug/ml ampicillin overnight at 37 oC with shaking (@ 230 rpm).
The SC was subsequently diluted 50X in fresh LB media containing antibi-
otic (100 ug/ml ampicillin) and grown at 37 oC to an OD600 = 0.6. β-Gal
protein expression was subsequently induced by the addition of isopropyl-1-
thio-B-d-galactopyranoside (IPTG) (0.3 mM). An uninduced control culture
was included for every protein sample. The induced and uninduced cultures
were subsequently incubated at 37 oC for 5 hours with shaking (@ 235 rpm) to
allow expression of proteins. Cultures were then centrifuged (4000 x g, 4 °C for
20 minutes), the supernatant discarded and the wet cell weight determined.
The pellets were resuspended in ice cold lysis buer (50 mM phosphate, pH
8, 300 mM NaCl, 10 mM Imidazole, 5 mM sodium metabisulphite and 0.1 %
NP40), 10 ml per 1 g cells. Phenylmethanesulfonylphosphonate (PMSF) was
added to a nal concentration of 10 mM as a protease inhibitor. The lysate
was sonicated on ice (1 min bursts, pulse mode, 50 % duty cycle) before in-
cubation at 4 oC for 30 minutes. Thereafter, the lysate was centrifuged (20
000 x g, 4 oC for 20 minutes), the supernatant collected, which contains the
protein of interest, and the pellet resuspended in lysis buer (20 ml) containing
PMSF (10 mM). The presence of the wildtype and E537D His6-β-Gal protein
was conrmed by sodium dodecyl sulphate polyacrylamide gel electrophoresis
(SDS PAGE), HisProbe and immunoblot analyses.
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3.2.2.2 Protein determination
Protein standards, ranging from 0 to 2.0 mg/ml with a working range between
202000 µg/ml, were prepared using the BCA method according to manu-
facturer's instructions. Bovine serum albumin (BSA) was used as a protein
standard and a standard curve was constructed from which the unknowns were
determined.
3.2.2.3 Sodium Dodecyl Sulphate Polyacrylamide Gel
Electrophoresis (SDS PAGE)
Preparation and Casting of the resolving and stacking gel (12 % T,
2.6 % C resolving gel and 4 % T, 2.6 % C stacking gel)
SDS PAGE was performed as described by Laemmli [88]. Resolving gel
buer (0.375 M Tris, pH 8.8, 0.1 % (m/v) SDS), (7 ml) was mixed with
Acrylamide stock solution (3 ml, 40 % (w/v)), 10 µl N,N,N'N'-tetramethilene
diamine (TEMED) and 100 µl of freshly prepared 20 % (m/v) Ammonium
persulfate solution and the gel was cast directly afterwards. A small volume
of deionized water was pipetted on top of the gel to even the gel front and
removed after the gel had polymerized (20 minutes). Stacking gel buer (0.126
M Tris, pH 6.8, 0.1 % SDS, m/v) (4.5 ml) was mixed with Acrylamide stock
solution (0.5 ml, 40 % (w/v)), 5 µl TEMED and 50 µl of freshly prepared 20
% (m/v) Ammonium persulfate solution and the gel poured. A 10 well comb
was inserted and the gel allowed to polymerize for 40 minutes before sample
application.
Sample and KaleidoscopeTM marker preparation
Each protein sample as well as a Rainbow KaleidoscopeTM marker was
treated with an equal volume of sample/treatment buer (0.004 % bromophenol
blue in 0.125 M Tris, 4 % (m/v) SDS, 20 % glycerol, 10 % (v/v) 2-mercaptoethanol,
pH 6.8) and boiled for 10 minutes at 90 oC. The samples were then kept on
ice until loaded onto the gel.
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Electrophoresis
The gel was assembled as per the manufacturer's instructions. The inner
and outer chamber of the electrophoresis tank were lled with electrophoresis
buer (25 mM Tris, 192 mM glycine and 0.1 % (m/v) SDS, pH 8.3), and the
protein samples were loaded. Electrophoresis was performed at 4 oC and a
constant voltage of 200 V.
Staining and destaining procedures
The gel was stained for 1 hour in Coomassie blue staining solution (0.125 %
(m/v) Coomassie Brilliant Blue R250, 50 % (v/v) methanol and 10 % (m/v)
acetic acid). The staining solution was decanted and the gel destained in
destain solution 1 (50 % (v/v) methanol and 10 % (v/v) acetic acid) overnight
followed by destain solution 2 (5 % (v/v) methanol and 7 % (v/v) acetic acid).
3.2.2.4 Immunoblot and HisProbe blot analyses
Electro-transfer
Proteins were separated by SDS PAGE as described in section 3.2.2.3 and
transferred to a nitrocellulose membrane as described by Strott [89] and per
manufacturer's instructions for the transfer equipment. Electro-transfer of
proteins to the nitrocellulose membrane was performed at ambient temperature
with a constant voltage of 110 V for 90 minutes with the electro-transfer tank
lled with transfer buer (50 mM Tris, pH 8.3, 192 mM glycine and 20 %
(v/v) methanol).
Immunoblot analysis
The membrane was blocked with casein buer (15 ml, 10 mM Tris, pH 7.6,
containing 0.15 M NaCl, 0.5 % casein and 0.02 % thiomersal) at 4 oC overnight
while agitating. The blot was washed 3 times with Tris buered saline tween
(TBST) (15 ml, 25 mM Tris, pH 7.6, 0.15 M NaCl and 0.05 % Tween-20) for 5
minutes before adding the primary antibody. A rabbit anti-β-Gal serum was
diluted, 1 in 100 000, in 2 % BSA/TBST (prepared from a 10 % BSA stock
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solution) as primary antibody and incubated with the membrane for 1 hour
at room temperature while agitating. Before adding the secondary antibody,
the blot was washed again several times with TBST. As secondary antibody,
an Anti-Rabbit IgG, Alkaline Phosphatase conjugated antibody was diluted,
1 in 30 000, in 2 % BSA/TBST and incubated with the blot for 1 hour at
room temperature. The blot was subsequently washed 3 times with TBST
before the substrate solution was added. As substrate solution a combination
of 33 µl BCIP-T (50 mg/ml in dimethylformamide) and 44 µl NBT (75 mg/ml
in 70 % dimethylformamide) in 10 ml Alkaline Phosphatase (AP) buer (100
mM Tris-HCl, pH 9.5, 100 mM NaCl and 10 mM MgCl2) was prepared and
incubated with the blot to yield a colour reaction on the blot.
HisProbe blot analysis
The membrane was blocked with 2 % BSA/TBST (15 ml) at 4 oC overnight
while agitating. Afterwards, the blot was washed with TBST for 5 minutes
before adding the HisProbeTM -HRP. This is a high specicity probe consisting
of horseradish peroxidise (HRP) coupled with nickel as probe specic for the
His6-tag cloned on the N-terminal of proteins (Figure 3.1) [90].
Figure 3.1: His-probe consisting of HRP coupled with nickel, used for the detection
of His6-tagged proteins, His6-β-Gal in this study [90].
The HisProbeTM -HRP was diluted, 1 in 6000, in 2 % BSA/TBST and
incubated with the blot for 1 hour at room temperature. The blot was sub-
sequently washed 4 times with TBST for 4 minutes before the substrate solu-
tion was added. As substrate, the Pierce ECL Western Blotting substrate
kit was used as an enhanced chemiluminescent substrate for the detection of
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HRP, prepared by the mixing of detection reagents 1 and 2 in a 1:1 ratio.
Chemiluminescence was used to verify the presence of the protein.
3.2.3 Wildtype and E537D His6-β-Gal IMAC
purication, dialysis and verication
3.2.3.1 IMAC
The supernatant samples of the expressed wildtype and E537D His6-β-Gal
were puried by anity chromatography using HiTrapTM chelating columns
and an AKTA Prime system [91]. The chelating sites of the columns were
saturated with a 100 mM NiSO4 solution and following this were equilibrated
with 9 column volumes of wash buer (50 mM phosphate, pH 8, 300 mM NaCl,
20 mM Imidazole, 25 mM β-mercaptoethanol, 5mM sodium metabisulphite,
10 % glycerol). The ltered protein sample (e.g. wildtype His6-β-Gal) was
loaded on the column followed by washing with 2 column volumes of the wash
buer to remove proteins that bound non-specically. The protein was eluted
using 8 column volumes of an imidazole gradient from 0 to 0.5 M. The same
protocol was used for the E537D His6-β-Gal. Tween-20 and sterile deionised
water was added to the fraction collection tube just before the puried protein
sample was collected, which is current practice in our laboratory [4] to prevent
the aggregation of the hexahistidine tags as well as to ensure solubility of the
puried His6-β-Gal.
3.2.3.2 Dialysis
Dialysis membrane (32 mm width with 20.4 mm diameter) (Spectra/Por) was
used together with a phosphate buered saline (PBS) buer, pH 7.4 contain-
ing 0.2 % Tween-20, to remove the imidazole and β-mercaptoethanol from
the puried protein samples that will interfere with downstream analyses. Af-
terwards, the presence of puried His6-β-Gal was conrmed by SDS PAGE,
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HisProbe and immunoblot analyses (refer to sections 3.2.2.3 and 3.2.2.4).
3.2.4 Enzymatic activity assays of wildtype and E537D
β-Gal with ONPG
β-Gal activity assays were performed according to Sanbrook et al. [92] as
adapted by Held [5]. A 20 mM stock solution of the ONPG substrate in 2X
reaction buer (200 mM sodiumphosphate, pH 7.0; 2 mM MgCl2; 100 mM
β-mercaptoethanol and 1.33 mg/ml ONPG in deionised water) was prepared
and a dilution series from 0 to 16 mM was made using 2X reaction buer
without ONPG as diluent with 8 dierent concentrations in total. Aliquots
of 100 µl for each dilution of ONPG were pipetted into the wells of a 96-well
microplate in replicates of 6. The reaction was initiated with the addition of
either 100 µl of the puried wildtype fraction (500X diluted) in triplicate or
pure E537D β-Gal fraction in triplicate, diluted in milliQ water if necessary.
After the addition of the puried protein the kinetic readings were initiated
immediately with absorbance determinations made every 5 seconds for a total
of 5 minutes at 37 oC. All absorbance determinations were made at 420 nm us-
ing a PowerWaveTM HT Microplate Spectrophotometer (BioTek Instruments)
with the reader controlled by Gen5 Data Analysis Software. Data was ana-
lyzed using GraphPad Prism version 5.00 for Windows, GraphPad Software,
San Diego California USA, www.graphpad.com.
3.3 Results and Discussion
3.3.1 SDS-PAGE and Western blotting verication
after protein expression
Wildtype and E537D His6-β-Gal proteins were expressed as previously de-
scribed. Each sample yielded both a supernatant and pellet sample after the
Stellenbosch University  http://scholar.sun.ac.za
CHAPTER 3. PROJECT CONTROLS: β-GALACTOSIDASE
CHARACTERIZATION 48
nal centrifugation step.
To verify the presence of β-Gal in the expressed protein samples as well
as the His6-tag cloned on the N-terminal of β-Gal, all samples were analyzed
through SDS PAGE, immunoblot and HisProbe blot analyses (Figure 3.2). β-
Gal from Aspergillus oryzae was included in the above analyses as a positive
control for untagged β-Gal.
SDS PAGE and immunoblot analysis (Figure 3.2(a) and (b)) conrmed that
β-Gal was expressed and present in both the supernatant and pellet samples
due to the corresponding size of the expressed proteins as well as the specicity
of the β-Gal primary antibody used. β-Gal occurs naturally as a 464 kDa
homotetramer, but should reveal a band corresponding to 116 kDa (monomer)
when analyzed through SDS-PAGE. The slight size dierence visible between
the control β-Gal (116 kDa) sample (Lane 2, Figure 3.2) and the expressed
β-Gal (120 kDa) sample (Lanes 310, Figure 3.2) is due to the His6-tag cloned
on the N-terminal of the protein that adds approximately 5 kDa to the protein
size. It is also clear from the data presented in Figure 3.2(a) that there is a
signicant dierence between the protein expression levels of the induced and
uninduced protein samples, while there is no remarkable dierence between
the expression levels of His6-β-Gal and His6-β-Gal_E537D. The HisProbe blot
analysis (Figure 3.2(c)) conrmed the presence of the His6-tag cloned on the
N-terminal of wildtype and E537D β-Gal through chemiluminescence of the
HisProbe. The control β-Gal (Lane 2, Figure 3.2(c)) was not detected during
the HisProbe blot analysis due to the absence of a His-tag.
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Figure 3.2: (a) SDS-PAGE, (b) Immunoblot and (c) HisProbe blot analyses of two
expressed E. coli Top 10 cell lines, one containing the pTrcHis-LacZ plasmid and the
other the mutated TrcHis-LacZ_E537D plasmid. The sizes of the molecular weight
marker are indicated on the left. Lane 1: Rainbow marker; Lane 2: β-Galactosidase
from Aspergillus oryzae as a positive control (Sigma-Aldrich) (8 µg); Lane 3: His6-
β-Gal expression induced with IPTG, supernatant sample (10 µg); Lane 4: His6-
β-Gal expression induced with IPTG, pellet sample (5 µg); Lane 5: His6-β-Gal
expression uninduced, supernatant sample (10 µg); Lane 6: His6-β-Gal expression
uninduced, pellet sample (5 µg); Lane 7: His6-β-Gal_E537D expression induced with
IPTG, supernatant sample (10 µg); Lane 8: His6-β-Gal_E537D expression induced
with IPTG, pellet sample (5 µg); Lane 9: His6-β-Gal_E537D expression uninduced,
supernatant sample (10 µg); Lane 10: His6-β-Gal_E537D expression uninduced,
pellet sample (5 µg).
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3.3.2 IMAC chromatograms of His6-tagged wildtype
and E537D β-Gal
IMAC purication of the wildtype and E537D His6-β-Gal crude protein mix-
tures (induced supernatant samples after expression) were performed by elut-
ing the specically immobilised His6-β-Gal with a high imidazole concentration
from the nickel chelated HiTrapTM column. The resuspended pellet/insoluble
fractions after protein expression were not used for protein purication since
most of the expressed β-Gal protein was present in the supernatant/soluble
fractions (refer to Figure 3.2).
Figure 3.3 illustrates the eectiveness of this IMAC technique in the puri-
cation of wildtype and E537D His6-β-Gal by the clear separation, which is
visible in the chromatograms, between the non-specic bound proteins (peak
at (a) 7.5 ml, (b) 11.0 ml), other histidine-rich proteins (peak at (a) 20.5
ml, (b) 50.0 ml) and our His6-tagged protein of interest (peak at (a) 30.0 ml,
(b) 79.0 ml). These purication chromatograms (Figure 3.3) for the IMAC
purication of wildtype and E537D His6-β-Gal are similar to those obtained
previously [4].
The puried wildtype and E537D His6-β-Gal fractions were dialyzed against
a PBS buer as described in section 3.2.3.2.
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Figure 3.3: Chromatograms obtained with IMAC purication of (a) wildtype and
(b) E537D His6-β-Gal, eluted with an Imidazole gradient of 0 to 0.5 M. The wild-
type His6-β-Gal IMAC purication was conducted using a 1 ml HiTrapTM chelating
column while a 5 ml HiTrapTM chelating column was used for the IMAC purication
of E537D His6-β-Gal.
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3.3.3 SDS-PAGE and Western blotting verication
after protein purication and dialysis
The protein concentrations of the puried wildtype and E537D His6-β-Gal
fractions were estimated to be 0.905 and 0.819 mg/ml, respectively while the
total protein yields were 3.6 and 12.3 mg (estimated with BCA protein de-
termination). These concentrations are similar to those previously obtained
by Dodd [4].
Although the protein concentrations were very similar, the dierence in
protein yield is due to the bigger volume of starter lysate (10 ml) used for the
purication of E537D His6-β-Gal with the 5 ml HiTrap
TM chelating column
that resulted in a larger puried fraction (6 ml) compared to the wildtype.
For wildtype His6-β-Gal only 5 ml starting lysate was used with the 1 ml
HiTrapTM chelating column that yielded a puried fraction of only 3 ml.
To verify the presence of β-Gal in the IMAC puried and dialyzed frac-
tions as well as the His6-tag cloned on the N-terminal of β-Gal; SDS PAGE,
immunoblot and HisProbe blot analyses (Figure 3.4) were performed.
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Figure 3.4: (a) SDS-PAGE, (b) Immunoblot and (c) HisProbe blot analyses of
IMAC puried wildtype and E537D His6-β-Gal. The sizes of the molecular weight
marker are indicated on the left. Lane 1: Rainbow marker; Lane 2: β-Galactosidase
from Aspergillus oryzae as a positive control (Sigma-Aldrich) (4 µg); Lane 3: Crude
supernatant after expression containing wildtype His6-β-Gal (8 µg); Lane 4: IMAC
puried wildtype His6-β-Gal (5 µg); Lane 5: Crude supernatant after expression
containing E537D His6-β-Gal (8 µg); Lane 6: IMAC puried E537D His6-β-Gal (5
µg).
SDS PAGE, immunoblot and HisProbe blot analyses conrmed that His6-
β-Gal (Lane 4, Figure 3.4) and E537D His6-β-Gal (Lane 6, Figure 3.4) were
present and puried from the crude supernatants after expression. This was
conrmed by the corresponding sizes of the protein present in the puried
fractions (Figure 3.4(a)), the high specicity of the primary antibody during
the immunoblot analysis (Figure 3.4(b)) as well as the denite detection of a
His-tagged protein at 120 kDa after chemiluminescence of the HisProbe (Figure
3.4(c)).
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3.3.4 Michaelis-Menton kinetic properties of wildtype
and E537D β-Gal
The eect of substrate concentration on the velocity of the enzymatic hydro-
lysis reaction of
ONPG
β−Galactosidase−−−−−−−−−→ o-nitrophenol(ONP ) +Galactose
was analyzed at 37 oC in triplicate with a PowerWaveTM HT Microplate
Spectrophotometer at 420 nm. ONPG is one of the many dierent substrates
of β-Gal with a β-D-galacto-pyranoside moiety that β-Gal can act upon. The
hydrolysis of the terminal β-D-galacto-pyranoside moiety of ONPG by β-Gal
results in the formation of the yellow (λ 420 nm) compound ONP [5].
The velocity of this enzymatic reaction increased drastically as the ONPG
substrate concentration is increased to 1.6 mM in the presence of the IMAC
puried wildtype and E537D His6-β-Gal enzymes (Figure 3.5).
An estimation of the Michaelis constants or Km and Vmax was made using
the Michaelis Menten equation and nonlinear regression with GraphPad Prism
version 5.00 for Windows, GraphPad Software, San Diego California USA,
www.graphpad.com. These results are summarized in Table 3.1.
Table 3.1: GraphPad Prism 5 calculated Michaelis constant (Km) and Vmax for
puried wildtype and E537D His6-β-Gal protein fractions.
Michaelis Menten Best t values
Vmax (µmol/min/mg) Km (mM)
Puried Wildtype His6-β-Gal 197.1 ± 4.005 0.21 ± 0.0186
Puried E537D His6-β-Gal 2.87 ± 0.077 0.28 ± 0.0311
The Vmax for wildtype His6-β-Gal in the hydrolysis of ONPG is 197.1
µmol/min/mg, which is more than 60 times that of E537D His6-β-Gal (Table
3.1). The Km values, on the other hand, were very similar i.e. 0.21 mM
for wildtype His6-β-Gal and 0.28 mM for E537D His6-β-Gal. Through these
results, it is, therefore, conrmed that the E537D point mutation reduces
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Figure 3.5: Eect of substrate concentration on enzyme velocity. Wildtype and
E537D His6-β-Gal reacted with increasing concentrations of ONPG and the ab-
sorbencies were kinetically determined. The average velocity was then plotted
against the accompanying ONPG concentration using GraphPad Prism 5 and the
Michaelis-Menten equation values for Km and Vmax calculated. Error bars indicate
standard error of the mean (SEM), n = 3.
the enzymatic activity of β-Gal signicantly without signicantly altering its
substrate binding ability, which is in agreement with previous results from
Dodd [4]. The individual values were also similar to those obtained by Dodd
[4].
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3.4 Conclusion
The isolation of wildtype and E537D His6-β-Gal via IMAC, produced chroma-
tograms very similar to those obtained by Dodd [4] with a clear separation of
His6-β-Gal from other proteins present in the starting lysate and a high level
of purication reproducibility. The purity of the IMAC obtained wildtype and
E537D His6-β-Gal, investigated and veried through SDS PAGE and Werstern
blotting, also revealed similar results.
The new microtitre plate assay for β-Gal activity investigations with ONPG
revealed similar results to the previously used test tube assay. More spe-
cically, the Michaelis Menten individual constants for both wildtype and
E537D His6-β-Gal was similar to those obtained by Dodd [4]. A Vmax of
2.87 µmol/min/mg for E537D His6-β-Gal similar to 2 µmol/min/mg protein
previously obtained by Dodd and a Km of 0.28 mM for E537D His6-β-Gal
similar to 0.27 mM previously obtained by Dodd [4].
Pure and active wildtype as well as E537D His6-β-Gal have now been ob-
tained, but before these could be covalently attached to functionalized mag-
netic nanoparticles, the three dimensional structure and topography of β-Gal
had to be investigated to determine the most accessible functional groups to
be targeted during the subsequent covalent coupling step. This aspect will be
discussed in Chapter 4.






The purpose of this investigation was to study the three dimensional struc-
ture and topography of β-Gal; the surface accessibility of certain functional
groups; and to determine the optimum surface groups that could be targeted
for covalent enzyme immobilisation to MNPs.
Due to the large size of the β-Gal tetramer (464 kDa), not many researchers
have investigated the specics regarding ligand binding and functional group
accessibility. However, β-Gal has been crystalised by other research groups
[93] and we could therefore look at the crystal structure and assess the best
method for immobilisation by evaluating the availability of acidic and basic
surface residues with available molecular visualization tools. This was not an
in depth study since the immobilisation procedure, attempted in Chapter 5,
was random and not directed at any specic one amino acid group or peptide
chain but rather at basic or acidic residues in general.
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After this structural investigation the most appropriate amino acid func-
tional group, according to theoretical calculations, to be targeted during the
subsequent coupling step would be selected.
4.2 Materials and Methods
4.2.1 GenBank Database
GenBank (http://www.ncbi.nlm.nih.gov/genbank/) is a NIH genetic sequence
database, which provides access to a well organized and annotated collection
of all the DNA sequences that are currently available to the public [94]. The
sources of β-Gal are endless but we more specically chose β-Gal from E. coli
strain K-12 substrain MG1655 since this is the exact strain Dodd [4] used for
the PCR amplication and cloning of the LacZ gene from E. coli.
4.2.2 YASARA 11.3.2 (Yet Another Scientic Articial
Reality Application)
YASARA is a well formulated and user-friendly molecular-graphics, -modeling
and -simulation program. YASARA has several unique features with an in-
tuitive user interface, photorealistic graphics and support for aordable auto-
stereoscopic displays, shutter glasses and input devices. The portable vector
language (PVL) of YASARA allows for the visualization of even the largest pro-
teins and enables true interactive real-time simulations (http://www.yasara.org/).
Here, YASARA was used to calculate and visualize the molecular surface of our
protein of interest and to distinguish between the basic and acidic functional
groups through dierential colouring.
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4.2.3 DS Viewer Pro 5.0
DS Viewer Pro 5.0 is a software tool that provides high-quality molecular
visualization. This tool provides many dierent ways of displaying atomic and
molecular information on a peptide or protein of interest. DS Viewer Pro 5.0
is user friendly and allowed for the clear display of the sidechains of specied
amino acids in the tertiary structure of the enzyme to assess the orientation
and accessibility of functional groups.
4.3 Results and Discussion
4.3.1 β-Galactosidase primary amino acid sequence
The primary amino acid sequence of β-Gal from E. coli in FASTA format was
accessed from GenBank Database (http://www.ncbi.nlm.nih.gov/genbank) us-
ing NCBI software (Figure 4.1).
Figure 4.1: Primary structure of β-Gal in FASTA format. E refers to position 537
in the sequence that was targeted during site-directed mutagenesis by Dodd in 2011
[4].
The primary amino acid sequence of 1023 amino acid residues were used
to calculate the amino acid composition and molecular percentages with DS
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ViewerPro 5.0 software. Table 4.1 contains the amino acid composition of one
subunit of β-Gal.
Table 4.1: Amino acid composition of β-Gal (gi|1657540) calculated using DS
ViewerPro software.
Amino Acid Number Mol %
Asp D 64 6.25
Glu E 62 6.05
Lys K 20 1.95
Arg R 66 6.45
His H 34 3.32
Cys C 16 1.56
Met M 24 2.34
Leu L 96 9.38
Ile I 39 3.81
Val V 64 6.25
Phe F 38 3.71
Pro P 62 6.05
Ala A 77 7.52
Asn N 47 4.59
Gln Q 58 5.66
Gly G 71 6.93
Ser S 60 5.86
Thr T 56 5.47
Trp W 39 3.81
Tyr Y 31 3.03
It was calculated from Table 4.1 that there were approximately equal
amounts of acidic (126) and basic (120) residues. The sum of the molecu-
lar percentages of the acidic residues (Asp and Glu) was 12.3 % and that of
the basic residues (Lys, Arg and His) was 11.72 %. It can therefore be assumed
that these functional group containing amino acid residues are similar with re-
gards to abundance in the homotetrameric form of the enzyme. β-Gal also
contains a relatively small amount (3.90 %) of thiol group containing amino
acid residues (Cys and Met) that could also potentially be targeted during
enzyme immobilisation. The neutral amino acid residues (Leu, Ile, Val, Phe,
Pro and Ala) are the most predominant (36.72 %) in this enzyme of interest.
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4.3.2 Investigation into a possible functional group as
target for the covalent immobilisation of β-Gal
4.3.2.1 Secondary structure representation
The secondary structure motifs of β-Gal from E. coli was visualized within
the homotetrameric tertiary structure of the enzyme using YASARA software
(DOI:10.2210/pdb1hn1/pdb). In Figure 4.2 the β-sheets are visible in red
and the α-helixes in blue. The four active sites are surrounded by several β-
sheets and α-helixes, which may be responsible for the conserved deep pocket
conformation of the β-Gal active site.
Figure 4.2: Secondary structure motifs of β-Gal from E. coli strain K-12 substrain
MG1655 dierentially coloured. β-Sheets visible in red, α-helixes in blue, random
coils (cyan) and turns (yellow). Arrows indicate 4 active sites present in the ho-
motetrameric tertiary structure.
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4.3.2.2 Tertiary structure
By using YASARA and DS ViewerPro the crystal three dimensional structure
of β-Gal from E. coli was visualized (Figure 4.3). In this gure, both the ball
and stick style (Figure 4.3(a)) and the ribbon style (Figure 4.3(b)) visualization
were used to represent the three dimensional structure of β-Gal.
As previously mentioned, β-Gal is a homotetramer with monomers of 116
kDa each. Three amino acids, Met502, Glu537 and Glu461, which have been
shown to be involved in the catalytic activity [19] are indicated in Figure
4.3(b).
Figure 4.3: Three dimensional structure of β-Gal. (a) Four subunits of homotetra-
mer dierentially coloured in ball and stick style. (b) One subunit of the homotet-
ramer indicated in green with the primary structure and orientation of the amino
acid residues located to a single active site indicated in dierent colours i.e. Glu461
(Red), Met502 (Yellow) and Glu537 (Blue).
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4.3.2.3 Visualization of functional group orientation
To determine the optimum functional group, with regards to abundance and
accessibility, to be targeted for potential covalent immobilisation of this com-
plex enzyme, a more in-depth investigation into the accessibility and orienta-
tion of the functional groups of the basic and acidic amino acid residues was
necessary. Using DS ViewerPro 5.0 all of these could be calculated or visual-
ized.
Figure 4.4 depicts the accessibility of the acidic amino acid (Asp and Glu)
residues of β-Gal. It seems as though the carboxylic groups of the acidic
residues are directed more towards the inside of the homotetramer. On the
other hand, it appears as though the amino groups of the basic residues (Lys,
Arg and His) (Figure 4.5) are directed more towards the outside of the enzyme.
However, these predictions are insucient since it only relies on side chain
orientation and cannot be used as the only information on deciding which
functional group to be targeted for potential peptide bond formation for the
ultimate covalent immobilisation of β-Gal.
Figure 4.4: Accessibility of functional groups of acidic amino acid (Asp and Glu)
residues of β-Gal, indicated in yellow, as visualized with DS ViewerPro software.
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Figure 4.5: Accessibility of functional groups of basic amino acid (Lys, Arg and
His) residues of β-Gal, indicated in yellow, as visualized with DS ViewerPro software.
YASARA software was then used to calculate and visualize the molecular
surface of β-Gal to support the previous accessibility investigation and to also
incorporate the area and volume taken up by each sidechain. Here, Figure 4.6,
the molecular surface of the functional groups were dierentially coloured to
visualize the surface accessibility of these groups. The carboxylic functional
groups (acidic residues) were coloured in red while the amine functional groups
(basic residues) were coloured in green.
From Figure 4.6 it appears as though both these functional groups are
equally accessible when the area and volume of the sidechains are also taken
into consideration. It was, therefore, decided that any one of these groups
could be targeted for the potential covalent immobilisation of β-Gal.
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Figure 4.6: Molecular surface accessibility of functional groups of acidic and basic
amino acid residues of β-Gal. Acidic amino acid residues indicated in red and basic
in green, as visualized with YASARA software.
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The thiol group of Cysteine residues is another possible target for cova-
lent enzyme immobilisation through the formation of a disulphide bridge. As
depicted in Figure 4.7, the functional thiol group of the cysteine residues is
protected in the tertiary structure of β-Gal. The cysteine residues of β-Gal
would therefore not be targeted during potential immobilisation strategies in
the subsequent chapters.
Figure 4.7: Accessibility of functional groups of cysteine amino acid residues of
β-Gal, indicated in yellow, as visualized with DS ViewerPro software.(a) β-Gal ho-
motetramer visible with cysteine residues (yellow) indicated in one (green) of the
four subunits. (b) Enlarged version of (a) with the cysteine residues more visible.
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4.4 Conclusion
From the three dimensional structural investigation of β-Gal it appears as
though the four active sites in the homotetrameric form of the enzyme are
equally accessible to the ligand. The abundance as well as the molecular
surface accessibility investigation of the functional groups of the basic and
acidic amino acid residues indicated both of these to be equally abundant and
accessible. It is due to this nding that it was decided that both the -COOH
and -NH3 could be targeted during the covalent coupling of the protein to the
MNPs. Furthermore, this coupling of the protein to the MNPs would then be
random since either the carboxylic groups or amine groups as a whole would
be targeted instead of directing the coupling towards a single site.








The random covalent immobilisation of E537D His6-β-Gal to MNPs was per-
formed on commercially available surface activated MNPs - uidMAG-Amine
(Figure 5.1), which has a superparamagnetic magnetite core coated with a
amino silane polymer matrix with surface accessible amine functional groups.
According to Van den Berg et al. [95], controlled covalent immobilisation is
highly desirable since the binding between the protein and surface is strong
and permanent. The immobilisation strategy employed aimed to target the
surface accessible amino acid groups of β-Gal to be covalently linked to the
amine groups on the surface activated uidMAG-Amine particles. Two dier-
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ent covalent immobilisation strategies were investigated and compared to yield
these functional immobilised enzyme particles.
Figure 5.1: Chemicell uidMAG-Amine product representation (Article no. 4121,
200 nm).
N-(3-Dimethylaminopropyl)-N'-ethylcarbodiimide hydrochloride (EDC) (Fig-
ure 5.2) is a coupling agent widely used for the covalent coupling of proteins
to solid supports [63]. The mechanism of action of EDC relies on the fact that
EDC activates carboxylic groups by forming a reactive intermediate product
called O-acylisourea. This reactive intermediate, containing a good leaving
group, catalyzes the amide bond formation between the activated carboxylic
group and a primary amine group. Isourea, with a yellowish colour, is formed
as a by-product and can be easily removed through several wash steps with
buer or water [96]. EDC is also known as a "zero-length" cross-linking agent
since the amide bond is formed without leaving a spacer molecule [97].
Although EDC has previously been used by a number of researchers, for
covalent coupling, the results of a number of such studies lacked the controls
required to eliminate the possibility of protein adsorption. These discrepancies
brought into question the feasibility of applying EDC in protein immobilisation
studies. However, manufacturer's instructions (uidMAG-Amine, Chemicell)
recommended using EDC and it is for this reason that the EDC activation
of the carboxylic groups present in the protein of interest was performed in
Stellenbosch University  http://scholar.sun.ac.za
CHAPTER 5. A COMPARISON BETWEEN EDC AND GLUTARALDEHYDE
FOR RANDOM COVALENT IMMOBILISATION OF E537D β-GAL 70
Figure 5.2: Chemical structure of N-(3-Dimethylaminopropyl)-N'-
ethylcarbodiimide hydrochloride (EDC).
this study. The extremely reactive intermediate, O-acylisourea, was used to
catalyze the coupling of the surface accessible carboxylic groups, present on
the protein, to the primary functional amine-groups on the surface of the
uidMAG-Amine particles through the formation of amide bonds.
Glutaraldehyde (Figure 5.3) is another well-known and very eective pro-
tein cross-linking agent, used to yield functional immobilised enzyme particles.
Glutaraldehyde is very reactive towards proteins, especially in its application
in the production of insoluble enzymes [98]. It can react with several functional
groups on proteins, such as amine, phenol, thiol and imidazole, as nucleophiles
are the most reactive amino acid side-chains [98]. In addition, various aldehyde
reactivities have been reported with lysine, tryptophane, tyrosine, phenylalan-
ine, cysteine, histidine, proline, glycine, glycylglycine, serine and arginine [98].
It is, therefore, possible to rank the reactivity of aldehydes towards reactive
moieties of amino acids in increasing order of reactivity as follows: hydroxyl
groups, secondary amino, guanidinyl, α-amino and ε-amino as the most react-
ive towards aldehydes [98].
Aldehydes, like glutaraldehyde, are usually expected to form Schi bases
upon nucleophilic attack by the amine groups of residues in the protein of in-
terest [99]. These Schi bases are, however, unstable under acidic conditions
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Figure 5.3: Chemical structure of monomeric glutaraldehyde.
and usually tend to break down into the separate aldehyde and amine if not
reduced by a reducing agent like NaBH4, which converts the unstable Schi
base to a stable secondary amine [100]. In contrast, it appears as though
the reaction of glutaraldehyde with an amino group is not likely to follow the
above mentioned mechanism but is instead exceptionally stable under extreme
pHs and temperatures [98; 100]. It is for this reason that the simple mechan-
ism, where both ends of monomeric glutaraldehyde reacts with amino groups
through a Schi base, has been ruled out and that cross-linking of proteins
with glutaraldehyde does not require a reducing agent [98]. Refer to [98] for
a more detailed description of glutaraldehyde behaviour in aqueous solutions
with emphasis on reactions with proteins and enzyme cross-linking.
It is, thus, clear from the above that apart from all the available liter-
ature on glutaraldehyde cross-linking and proposed molecular reactive forms,
no single mechanism seems to be responsible for glutaraldehyde protein cross-
linking. Evidence suggests that the multi-component nature of glutaralde-
hyde presents at least 13 dierent forms depending on reaction conditions
[98]. Therefore conditions, including pH, ionic strength, temperature, enzyme
and reagent concentrations, and the reaction time all need to be optimized for
every protein of interest. Some guidelines regarding the pH, temperature and
reaction times are provided by Migneault et al. [98]. These suggestions include
the following: maintain the pH of the solution close to the isoelectric point
(pI) of the protein [101], reaction temperatures of 4 oC require longer reaction
times (618 h) [102]; while reactions at ambient temperatures are completed
within 4 h [103].
The main dierence between EDC and glutararaldehyde, expected to in-
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uence the amount of protein that can be coupled to the MNPs as well as the
activity of the immobilised enzyme, is the "zero-length" cross-linking of EDC
compared to the incorporation of a spacer with glutaraldehyde cross-linking.
This spacer incorporated with glutaraldehyde cross-linking might allow more
protein to be coupled to the MNP surface as well as limit steric hindrances
[61].
5.2 Materials and Methods
5.2.1 Reagents and chemicals
Crude extract of E537D His6-β-Gal overexpressed in E. coli (Top 10 One
Shot®) was produced and puried through IMAC as previously described
(section 3.2.2.1 and 3.2.3.1). FluidMAG-Amine (Article no. 4121, 200 nm
diameter), amine surface activated magnetic nanoparticles, were ordered from
Chemicell (Berlin, Germany). Commercial grade N-(3-Dimethylaminopropyl)-
N'-ethylcarbodiimide hydrochloride (EDC) and glutaraldehyde solution 50 wt.
% in water were purchased from Sigma-Aldrich Chemical Co.(Germany) and
all chemicals used for the preparation of buers and solutions were of analytical
grade or higher and purchased from Merck, Sigma-Aldrich Chemical Co. or
Bio-Rad. An Ultra Pure Milli-Q water system was used to produce reagent
grade water used in all buers and experiments.
5.2.2 Covalent coupling of E537D β-Gal to
uidMAG-Amine by EDC
EDC with a Mw=191.7 g/mol, is a water soluble, white to o-white coloured
powder. It is stable but sensitive to moisture as well as being incompatible
with strong oxidizing agents and strong acids.
IMAC puried protein was dialyzed against a PBS buer, pH 7.4 (refer to
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section 3.2.3.2). FluidMAG-Amine particles (1 mg (40 µl) of the 25 mg/ml
stock suspension) were added to clean microtubes where each microtube rep-
resented a potential immobilisation reaction between the protein of interest
and 1 mg of particles. The EDC solution (freshly prepared immediately be-
fore use by dissolving EDC (5 mg) in sterile deionised water (0.075 ml)) (15
µl) was rapidly mixed into each reaction tube by means of a vortex (only the
necessary volume of EDC was prepared each time in the above ratios). E537D
β-Gal was added to the uidMAG-Amine and EDC mixture in the tubes and
gently mixed on a Labroller for 2 hours at room temperature. After the two
hour incubation period, the particles were separated from the slightly yellow
supernatant through magnetic decantation and the supernatant carefully re-
moved with a pipette (labeled: supernatant). The particles were then washed
three times with PBS buer (100 µl, pH 7.4) and the supernatant again sep-
arated from the particles through magnetic decantation (labeled: wash steps
13). Finally the particles were resuspended in PBS buer (100 µl, pH 7.4)
and stored at 4 oC for further analysis. All supernatant and wash step samples
were analyzed to calculate the amount of E537D β-Gal immobilised to 1 mg
of particles (refer to section 5.2.4).
The amount of E537D β-Gal immobilised to the uidMAG-Amine was
optimized experimentally. Dierent amounts (20, 40, 60, 80, 90, 100, 120,
130, 140, 150 and 160 µg) of a 1 mg/ml E537D β-Gal solution were added to
the uidMAG-Amine in triplicate and all supernatant and wash step samples
analyzed (refer to section 5.2.4). The resulting data were used to draw a
saturation curve and determine the optimum amount of protein (inµg) that
could be immobilised to 1 mg of uidMAG-Amine as represented by GraphPad
Prism version 5.00 for Windows, GraphPad Software, San Diego California
USA, www.graphpad.com.
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5.2.3 Covalent cross-linking of E537D β-Gal to
uidMAG-Amine with glutaraldehyde
Glutaraldehyde is a linear, 5-carbon dialdehyde that is clear and colourless to
pale-straw in colour. It is a pungent oily liquid that is soluble in alcohol, water
and organic solvents.
The covalent immobilisation of E537D β-Gal to uidMAG-Amine via cross-
linking with glutaraldehyde was performed as described by Rossi et al. [104]
and slightly adapted for the purpose of this study. It must be noted that
Rossi et al. made use of glutaraldehyde to immobilise glucose oxidase, and not
β-Gal, to amine functionalized MNPs.
The IMAC puried protein was dialyzed against a PBS buer, pH 7.4 (refer
section 3.2.3.2). FluidMAG-Amine particles (1 mg) were re-dispersed in 10 %
glutaraldehyde PBS solution, pH 7.4 (400 µl), by sonication in microtubes
and subsequent gentle mixing on a Labroller for 1 hour at room temperat-
ure. Hereafter, the particles were separated through magnetic decantation,
washed twice with PBS buer (100 µl, pH 7.4) and nally re-suspended in
PBS buer (20 µl, pH 7.4). E537D β-Gal was added to the glutaraldehyde
functionalized particles and gently mixed for four hours at ambient temperat-
ure. The particles were subsequently separated through magnetic decantation,
washed three times in PBS buer, pH 7.4 and once in PBS buer, pH 6.5 be-
fore resuspension in PBS buer (100 µl, pH 7.4). The supernatant, and wash
step samples, were kept for further analysis (refer to section 5.2.4). The PBS
re-suspended particle samples were stored at 4 oC until further analysis.
As for the EDC coupling method for protein immobilisation, the amount
of E537D β-Gal immobilised to the uidMAG-Amine was also optimized for
the glutaraldehyde cross-linking method. Apart from this, the solution pH,
reaction temperature and time were also optimized according to literature
[98].
It was suggested by Jansen et al. [101] that the pH of the solution should be
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as close as possible to the pI of the protein of interest, which is 5.3 for β-Gal,
since protein charge plays an important role in intermolecular cross-linking
that is required for insolubilization. On the other hand, the optimal reactivity
pH for aqueous glutaraldehyde should also be taken into consideration. Most
glutaraldehyde immobilisation experiments are currently conducted at a neut-
ral or slightly alkaline pH. It was therefore decided to keep the reaction pH at
the PBS buer pH of 7.4 since β-Gal is stable and active over a wide pH range
(5 - 8.5).
Tween-20 was included during the immobilisation strategies, as advised by
Van den Berg et al. [95], since they found that the coincubation of protein
and Tween during the incubation step for immobilisation eectively inhibited
hydrophobic association of the protein with surfaces. Tween 20, to a nal
concentration of 0.2 %, was therefore included in protein and uidMAG-Amine
incubations during the coupling step.
The glutaraldehyde coupling step was ultimately performed at ambient
temperature for four hours as current practice for glutaraldehyde immobil-
isation studies, suggested by Krogh et al. [103], since β-Gal is not a labile
molecule. The incubation time and temperature were also investigated exper-
imentally and the results indicated that the reaction was complete within four
hours at ambient temperature, whereas the reaction took signicantly longer
to complete at 4 oC. By performing the coupling step as described above, the
immobilisation reaction was allowed to occur under physiological conditions
(pH 7.4 and 25 oC) as previously mentioned in section 2.4.4 (Camarero [61]).
5.2.4 Determination of the amount of E537D β-Gal
protein immobilised to 1 mg uidMAG-Amine
BCA protein determination assays (refer to section 3.2.2.2) were used to de-
termine the maximum amount of E537D β-Gal immobilised to 1 mg of uidMAG-
Amine through EDC coupling and glutaraldehyde cross-linking.
Stellenbosch University  http://scholar.sun.ac.za
CHAPTER 5. A COMPARISON BETWEEN EDC AND GLUTARALDEHYDE
FOR RANDOM COVALENT IMMOBILISATION OF E537D β-GAL 76
During the course of the optimization experiment, the temperature (am-
bient), pH (7.4), incubation time (2 hours for EDC method and 4 hours for
glutaraldehyde method), reaction volume (215 µl for the EDC method and
200 µl for the glutaraldehyde method) and amount of uidMAG-Amine (1
mg) were kept constant while the concentration of E537D β-Gal was varied
between 0 and 0.8 mg/ml. The reason for the slightly bigger reaction volume
for the EDC immobilisation samples is because the EDC solution was part of
the nal reaction volume (refer to section 5.2.2). By comparing the protein
estimation of the supernatant before and after immobilisation (including the
wash step samples), the dierence in enzyme concentration indicated the max-
imum amount (in µg) of E537D β-Gal immobilised to 1 mg uidMAG-Amine.
This method of measuring the loss of protein in solution is a well-documented
indirect method to determine the amount of immobilised protein [63].
5.2.5 Adsorption of protein and removal by detergent
In the desorption experiment, to remove all protein that was not covalently
linked to the uidMAG-Amine, the EDC and glutaraldehyde coupled E537D
β-Gal particles as well as a control sample without a coupling agent, were
resuspended in a 2 % SDS-PBS buer, pH 7.4, solution at 50 oC for 1 hour with
mixing as previously described by Van den Berg et al. [95]. The particles were
subsequently removed from the SDS-PBS solution by magnetic decantation
and the supernatant stored at 4 oC. The particles were washed several times
with sterile deionized water, lyophilized and analyzed by Attenuated Total
Reectance Fourier Transform Infrared vibrational spectroscopy (ATR-FTIR)
to determine non-specic as well as specic covalent binding of E537D β-Gal.
The supernatant samples, obtained from the SDS wash step, were also analyzed
by a protein concentration determination to estimate the amount (in µg) of
E537D β-Gal that was originally physically adsorbed to the uidMAG-Amine
surface and was eectively desorbed during the detergent wash step.
Stellenbosch University  http://scholar.sun.ac.za
CHAPTER 5. A COMPARISON BETWEEN EDC AND GLUTARALDEHYDE
FOR RANDOM COVALENT IMMOBILISATION OF E537D β-GAL 77
5.2.6 Verication of covalent immobilisation through
Attenuated Total Reectance Fourier Transform
Infrared vibrational spectroscopy (ATR-FTIR)
Samples of the uidMAG-Amine coupled E537D β-Gal (via EDC (section
5.2.2) or glutaraldehyde (section 5.2.3) immobilisation) as well as two con-
trol samples, one containing pure uidMAG-Amine and the other containing
uidMAG-Amine mixed with E537D β-Gal in the absence of coupling or cross-
linking agents, were prepared together with the SDS washed samples (section
5.2.5) for ATR-FTIR analysis.
Sample preparation consisted of the washing and resuspension of samples
in sterile deionised water followed by overnight lyophilisation. The resulting
powdered samples were used for the analysis.
ATR-FTIR analysis was performed by means of OMNIC software on a
Thermo Scientic Nicolet iS10 SMART iTR at the Department of Polymer
Science, Stellenbosch University. The absorbance spectra of all the samples
were collected and compared to the control, pure uidMAG-Amine.
5.2.7 Verication of uidMAG-Amine surface coating
with E537D β-Gal using Transmission Electron
Microscopy (TEM)
TEM was conducted at the University of Cape Town by Mr. Franscious Cum-
mings. The light microscope used was a TECNAI F20 Field Emission gun
transmission electron microscope, operated at 200 kV with the collection of
bright eld images. Nitrogen gas was used to cool the TEM system down
before sample analysis.
Specimen preparation consisted of the washing (three times with 100 µl)
and resuspension (40 µl) of the uncoated and protein coated uidMAG-Amine
samples in sterile deionised water. The samples were then prepared by diluting
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3 µl of the suspended particles in 20 µl of deionised water. The suspensions
were then sonicated for 10 minutes to improve the dispersion of the specimen
within the solution. After sonication one drop of the uncoated uidMAG-
Amine particles was placed on a glow-discharged carbon coated copper grid
(300 mesh). The glow-discharge process renders the grids hydrophilic, which
enables the water-dispersed samples to spread out over the grid. The uncoated
uidMAG-Amine sample was then allowed to dry under a 240 W light source.
The protein coated samples, i.e. E537D β-Gal coated uidMAG-Amine via
EDC and via glutaraldehyde cross-linking, were stained using uranyl acetate.
One drop of the sample was placed on a glow-discharged carbon coated cop-
per grid for 30 seconds, whereafter excess sample was blotted o using lter
paper. The grid was subsequently placed on a drop of uranyl acetate (2 wt%
in deionised water), blotted dry and this last staining step repeated, hereafter
the grid was allowed to dry in air until analysis.
5.2.8 Verication of uidMAG-Amine surface coating
with E537D β-Gal using Scanning Electron
Microscopy (SEM)
SEM analysis was conducted at the Electron Microscope Unit of the Univer-
sity of Cape Town by Ms. Miranda Waldron in order to study the surface
topography and composition of the MNPs. The microscope used was a Nova
NanoSEM 230 and was operated at a high voltage of 5.00 kV and a chamber
pressure of 1.00 mbar.
Specimen preparation consisted of the overnight lyophilization of the un-
coated and protein coated uidMAG-Amine samples. The powdered samples
were then located to a SEM stub that was coated with a thin layer of homemade
carbon glue, and numbered. After sample application the excess powder was
blown o and the specimens coated with gold for 30 minutes. Hereafter the
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specimens were visualized by SEM.
5.3 Results and Discussion
5.3.1 BCA protein determination of supernatant
samples to verify protein immobilisation
As expected, the BCA protein determination of the supernatant samples, be-
fore and after E537D β-Gal immobilisation, to uidMAG-Amine via the two
strategies, yielded a lower protein concentration after immobilisation than be-
fore immobilisation. This was indicative of protein immobilisation to uidMAG-
Amine, but did not suggest or indicate covalent attachment. The possible
covalent attachment needed to be investigated and veried separately.
From Tables 5.1 and 5.2 it is evident that considerably more protein re-
mained in the supernatant after immobilisation as the protein concentration of
the protein, incubated with the particles, was increased (refer to section 5.2.4
for increased protein concentrations). This phenomenon was more pronounced
for the supernatant samples obtained from the EDC method (Table 5.1, 61 % of
0.8 mg/ml protein remained in the supernatant) than for the samples obtained
from the glutaraldehyde method (Table 5.2, 45 % of 0.8 mg/ml protein re-
mained in the supernatant). However, control samples with uidMAG-Amine
and E537D β-Gal, where the cross-linking and coupling agents were omitted,
also indicated a decreased protein concentration after the immobilisation in-
cubation step (data not shown). This suggested the physical adsorption of
protein to the uidMAG-Amine. In order to distinguish between the physic-
ally adsorbed and covalently attached protein, as well as to verify the covalent
immobilisation of the protein of interest, a detergent wash step was incorpor-
ated after the normal coupling step to remove any physi-sorption of protein
(refer to section 5.2.5).
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5.3.2 Verication of desorption of adsorbed protein
A SDS wash step was employed after the immobilisation and PBS buer wash
steps to remove non covalently bound E537D β-Gal from the uidMAG-Amine.
These SDS-PBS wash solutions were kept for a protein determination to es-
timate the amount of protein removed during the detergent wash from the
uidMAG-Amine.
Observations made during the immobilisation and accompanying wash
steps was that the uidMAG-Amine-glutaraldehyde-protein sample was easier
to separate through magnetic decantation and stayed in solution for longer
periods before insolubilization than the accompanying EDC and protein ad-
sorption samples. This could suggest that the uidMAG-Amine-glutaraldehyde-
E537D β-Gal is more stable than the uidMAG-Amine-EDC-E537D β-Gal.
The protein determination data of the separate detergent wash steps were
used together with the previous protein determination data of section 5.3.1
to determine the saturation of 1 mg FluidMAG-Amine with E537D β-Gal via
EDC coupling or glutaraldehyde cross-linking (Figure 5.4 and 5.5).
The maximum amount of E537D β-Gal that could be immobilised to 1 mg
uidMAG-Amine via EDC coupling was 55 µg (Figure 5.4) while saturation
of 1 mg uidMAG-Amine via glutaraldehyde cross-linking was less clear but
reached at 80 µg (Figure 5.5). This is consistent with the the higher con-
centration of protein that remained in the supernatant after immobilisation
via EDC coupling as previously mentioned. It is therefore evident that more
E537D β-Gal could be covalently immobilised to uidMAG-Amine via glut-
araldehyde cross-linking, compared to EDC coupling. This phenomenon may
be due to the multi-component functional nature of gluteraldehyde that pro-
poses a variety of reactive forms that allows for much for β-Gal to be linked
to the uidMAG-Amine compared to EDC, which can only accommodate one
enzyme molecule per reactive intermediate. Signicantly more physical ad-
sorption also occurred with the EDC coupling strategy as compared to the
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glutaraldehyde cross-linking strategy, Figure 5.4 and 5.5.
Figure 5.4: Saturation of 1 mg uidMAG-Amine via EDC coupling before and
after the desorption of adsorbed E537D β-Gal as calculated by GraphPad Prism 5
software. Concentration on x-axis refers to the protein concentration in Table 5.1. •
: Before desorption of adsorbed protein, 4 : After desorption of adsorbed protein.
Error bars indicate SEM, n = 3.
Figure 5.5: Saturation of 1 mg uidMAG-Amine via glutaraldehyde cross-linking
before and after the desorption of adsorbed E537D β-Gal as calculated by GraphPad
Prism 5 software. Concentration on x-axis refers to the protein concentration in Table
5.2. • : Before desorption of adsorbed protein, 4 : After desorption of adsorbed
protein. Error bars indicate SEM, n = 3.
Stellenbosch University  http://scholar.sun.ac.za
CHAPTER 5. A COMPARISON BETWEEN EDC AND GLUTARALDEHYDE
FOR RANDOM COVALENT IMMOBILISATION OF E537D β-GAL 84
5.3.3 ATR-FTIR spectra
ATR-FTIR analysis was performed on the protein coated MNPs before and
after the desorption of adsorbed protein and the absorbencies of the dierent
samples collected and compared using OMNIC software (Figure 5.6). Figure
5.6 shows the amide peak absorbances in the infrared for these samples. The
amide peak absorbance range is 1680 - 1630 cm−1 for the C=O stretch whereas
N-H bending occurs in the region of 1640 - 1550 cm−1 for primary (I) and
secondary (II) amides, as labelled in Figure 5.6. The N-H stretch in primary
amides (-NH2) gives two bands near 3350 and 3180 cm
−1 whereas secondary
amides have one band (-NH) at about 3300 cm−1.
Almost all the protein adsorbed to the uidMAG-Amine surface for the
control sample with untreated uidMAG-Amine (Figure 5.6(a) turquoise spec-
trum) was removed during the subsequent SDS detergent wash step (Figure
5.6(a) red spectrum) when compared to the uidMAG-Amine control (Figure
5.6(b)). From this observation, where all the non-covalently coupled protein
was successfully removed during the detergent wash for the control sample,
it was assumed that the detergent wash step would remove any possible non-
covalently coupled protein from all the samples.
The presence of amide peaks in the EDC and glutaraldehyde spectra, after
the detergent wash, is indicative of covalent linkages. From this results it was,
therefore evident that E537D β-Gal was covalently attached to uidMAG-
Amine. It was, however, evident that some physi-sorption did occur with both
the EDC and glutaraldehyde methods as was evident when comparing the
before and after desorption graphs in section 5.3.2 and when comparing the
before and after desorption FTIR spectra in Figure 5.6.
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Figure 5.6: Infrared (ATR-FTIR) spectra of E537D β-Gal immobilised on
uidMAG-Amine through EDC coupling, glutaraldehyde cross-linking or physical
adsorption. (a) Protein attached during incubation on the glutaraldehyde treated
uidMAG-Amine (purple spectrum, unshifted at top) is retained after SDS washing
(dark green spectrum, unshifted in fourth position) [2 % SDS solution, 50 oC for 1
hour]. Protein attached during incubation with EDC and uidMAG-Amine (dark
blue spectrum, unshifted at third position) is also retained after SDS washing (pink
spectrum, unshifted in fth position). Protein attached during incubation on the
untreated uidMAG-Amine (turquoise spectrum, unshifted at second position) is
almost completely removed after SDS washing (red spectrum, unshifted at bottom)
when compared to (b) pure 200 nm uidMAG-Amine.
5.3.4 TEM images
Measurements of the uncoated control uidMAG-Amine particles made during
TEM analysis indicated these particles to be roughly between 8 and 15 nm in
diameter (Figure 5.8). The results from this TEM analysis of the uidMAG-
Amine is very similar to a TEM image of the uidMAG-Amine (200 nm) that
was requested and received from Chemicell (Berlin, Germany), Figure 5.7.
The protein coating of the particles via EDC and glutaraldehyde is not
that clearly visible from the TEM images shown below (Figures 5.9 and 5.10).
However, it appears as though these coated particles tend to be more clustered
(darker due to more layers) compared to the uncoated particles and it is plaus-
ible that this phenomenon is due to protein-protein and protein-particle cross-
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linking that occurred during the coupling step. It is also impossible to detect
any signicant dierence between the two immobilization strategies from these
TEM images.
Figure 5.7: TEM image requested from Chemicell (Berlin, Germany).
Figure 5.8: TEM images of uncoated uidMAG-Amine particles (a) 200 000 X
magnication (b) 470 000 X magnication with the size of the uncoated particles
calculated to be approximately 10 nm in diameter.
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Figure 5.9: TEM images of E537D β-Gal coated uidMAG-Amine via EDC coup-
ling (a) 100 000 X magnication (b) 340 000 X magnication.
Figure 5.10: TEM images of E537D β-Gal coated uidMAG-Amine via glutaral-
dehyde cross-linking (a) 100 000 X magnication (b) 340 000 X magnication.
5.3.5 SEM images
SEM images of the uncoated and coated uidMAG-Amine particles revealed
spherical particles with a size range between 50 and 80 nm. Unfortunately, due
to the wide variation in particle size, an increase in size due to protein coating
of the particles could not be calculated. Interestingly, the measurements of
the uncoated particles from the TEM analysis (Figure 5.8, 8 - 15 nm) and
the measurements taken during SEM analysis (Figure 5.11, 50 - 80 nm) were
very dierent. Both these analysis were performed on the same original batch
of uidMAG-Amine. It is, however, possible that during TEM analysis, the
electron beam only registered the core magnetite material of the particles and
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not the aminosilane matrix, while the electron beam during SEM analysis
scanned the surface, including the aminosilane matrix, during the analysis.
Another possible explanation could pertain to calibration dierences between
these two instruments.
In the images of the coated particles (Figures 5.12 and 5.13), a thin layer
coating the surface of the particles can be observed when compared to the un-
coated particles (Figure 5.11). Single particles are then also less distinguishable
and the particles appear even more clustered than the uncoated ones. The lat-
ter may be primarily due to the protein-particle cross-linking that was intended
during the coupling step, as well as possible protein-protein cross-linking that
was not intended as such, but most probably occurred. Again, no signicant
dierence between EDC and glutaraldehyde can be seen.
Figure 5.11: SEM images of uncoated uidMAG-Amine particles of two areas (a
and b) magnied by 100 000 with the size of the uncoated particles calculated to be
50 - 80 nm in diameter.
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Figure 5.12: SEM images of E537D β-Gal coated uidMAG-Amine particles via
EDC coupling of two areas (a and b) magnied by 100 000.
Figure 5.13: SEM images of E537D β-Gal coated uidMAG-Amine particles via
glutaraldehyde cross-linking of two areas (a and b) magnied by 100 000.
5.4 Conclusion
The random covalent immobilisation of E537D β-Gal to uidMAG-Amine via
EDC coupling and glutaraldehyde cross-linking was investigated and conrmed
by a series of analyses.
BCA protein determination assays indicated a loss in protein present in
the supernatant, used for the coupling step, after immobilisation compared to
Stellenbosch University  http://scholar.sun.ac.za
CHAPTER 5. A COMPARISON BETWEEN EDC AND GLUTARALDEHYDE
FOR RANDOM COVALENT IMMOBILISATION OF E537D β-GAL 90
before immobilisation. A detergent wash step, with a strong ionic surfactant,
SDS, indicated covalent protein attachment to the MNPs. This was evident
from the detergent's ability to only remove or separate a small amount of the
protein from the MNPs. The amount of protein desorbed by the detergent
only increased signicantly when 55 µg E537D β-Gal was reached for the
EDC coupling method and 80 µg for the glutaraldehyde cross-linking strategy
(Figures 5.4 and 5.5). ATR-FTIR analysis on these protein coated particles
further conrmed the presence of a covalent amide bond between the protein
and the MNPs (Figure 5.6). Although TEM and SEM analysis did not provide
clear images regarding protein surface coating of the MNPs, it was possible to
detect a dierence between the uncoated and protein coated particles. This is
therefore sucient evidence to conrm the covalent immobilisation of E537D
β-Gal to uidMAG-Amine via EDC coupling and glutaraldehyde cross-linking.
Furthermore, it was calculated that the glutaraldehyde cross-linking strategy
enabled an increased carrier capacity of E537D β-Gal protein to uidMAG-
Amine compared to the EDC coupling strategy.
It is noteworthy to mention here that these cross-linking strategies (EDC
and glutaraldehyde) result in strong, covalent bonds that cannot be reversed
under normal conditions and would prevent enzyme leakage from the MNPs.
The nal factor that was, however, to be determined, was whether the
EDC and glutaraldehyde immobilised E537D β-Gal to uidMAG-Amine had
retained their substrate binding ability and enzymatic activity. This aspect
would be investigated through immobilised binding assays in Chapter 6.







The successful covalent immobilisation of E537D β-Gal to uidMAG-Amine,
via two coupling strategies i.e. EDC coupling and glutaraldehyde cross-linking,
was discussed in Chapter 5. The covalent immobilisation of enzymes usually
results in some loss of activity due to the strong permanent bond that may
inuence enzyme structure, substrate binding ability and catalytic function.
The next step was, therefore, the characterization of the immobilised enzyme-
particle complexes with regards to retained enzymatic activity in order to
determine the ultimate binding potential for the removal of lactose from solu-
tion.
As described previously, a detergent wash step was employed to desorb any
non covalently bound enzyme from the uidMAG-Amine. For this purpose
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SDS was used as described by Van den Berg et al. [95]. SDS is, however, a
strong ionic surfactant that unfolds and denatures protein structure, usually
resulting in a loss of enzymatic activity. It was therefore necessary to determine
how SDS would inuence the enzymatic activity of β-Gal as well as to compare
SDS to alternative detergents for the same purpose.
Enzymatic characterization, of the covalently immobilised enzyme, included
the testing of the ligand binding ability with two β-Gal ligands, ONPG and
lactose, and thereafter the hydrolysis of the substrate (retained enzymatic
activity) to the accompanying products. The E537D mutated version of the
enzyme has a much lower enzymatic activity compared to the wildtype β-Gal,
as described in section 3.3.4. This would, therefore, allow the binding and re-
moval of lactose from milk accompanied by the hydrolysis of part of the lactose
to glucose and galactose (low enzymatic activity) to compensate for the loss
in sugar.
An immobilised form of the expressed and puried wildtype β-Gal en-
zyme was included during the activity optimization and characterization ex-
periments as a control.
6.1.1 Carbohydrate analysis
Carbohydrates occur in many food products and some carbohydrates can also
be used as food additives. A whole range of detection and analysis methods
for carbohydrates have been developed specically for monitoring the carbo-
hydrate content of foodstus. These, specically developed for the qualit-
ative and quantitative analysis of carbohydrates, can be divided into chro-
matographic [105], electrophoretic [106; 107], chemical (colorimetric, titration
and gravimetric), enzymatic activity (catalysis of specic reactions) and phys-
ical (infrared, density, refractive index and polarimetry) methods as well as
immunoassays [108]. The chromatographic methods are the most frequently
used to determine the type and concentration of mono- and oligosaccharides in
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foodstus. Chromatography allows for rapid, repeatable separation and quan-
tication of a wide range of carbohydrates. Chromatography, together with
radiolabeled substrates, was therefore used to characterize β-Gal activity in
this study. A short overview of these technologies will subsequently be given
as background.
6.1.1.1 Chromatography
Chromatographic methods used for carbohydrate analyses include gas chro-
matography (GC), thin layer chromatography (TLC) and high performance
liquid chromatography (HPLC). The nal separation and identication of car-
bohydrates is achieved by means of their partition coecients, sizes or polar-
ities depending on the stationary phase employed.
Gas Chromatography
Analysis by GC is based on the separation of a mixture of components
according to the degree of anity for or interaction of each component with a
liquid stationary phase. During GC analysis the components are vaporized in
a gas phase and separations occur at high temperatures. Components in the
mixture to be separated that express a higher anity for the stationary phase
would elute later while those with less of an anity for the stationary phase
would elute rst.
The GC analysis of carbohydrates is an established technique and one of the
main advantages is the small sample size that is required. Sample preparation
for GC analysis of carbohydrates is, however, laborious and involves several
steps, including derivitization [109], and may result in sample loss.
According to Rogatsky and Stein [110], routine quantitative GC accom-
panied by mass spectrometry (MS) analysis of carbohydrates are usually not
preferred because it requires multi-step sample preparation, pre-puried ana-
lytes and long runtimes.
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Thin layer Chromatography
For TLC, the separation of analytes occur on a stationary phase that usu-
ally consists of a thin layer coating on a square or rectangular, metal foil or
glass plate [105]. The separation can be based on either partition, adsorption,
ion-exchange, chiral or molecular exclusion principles depending on the sta-
tionary phase selected. The test sample is placed as either a spot or a thin
band near one end of the plate, whereafter this end of the plate is then placed
in a reservoir containing the mobile phase [105]. Naturally, due to capillary
action, the mobile phase passes over the plate until it is removed from the
reservoir or until the mobile phase front reaches the end of the plate [105].
Analytes in the test sample are ultimately separated at a rate determined by
their distribution coecients between the mobile and stationary phases. Here,
the movement of a given analyte is characterized by a retardation factor (Rf )
[105]. The main advantage of TLC is the speed and exibility whereby a num-
ber of constituents can be determined while, on the other hand, results are
dicult to reproduce.
High performance liquid Chromatography
HPLC analysis is where components of an applied sample are separated
by the continuous passage of the liquid mobile phase through the column con-
taining a stationary phase consisting of small particles. The small particles
are developed to withstand high pressures that result from back-pressure in
the column due to the great resistance to ow of the mobile phase [105]. The
columns generally used in HPLC analyses are made from stainless steel and
manufactured to withstand pressures of up to 5.5 X 107 Pa [105]. These are
then also further classied as either conventional or microbore columns where
microbore columns have several advantageous including reduced eluent con-
sumption due to slower ow rates and increased sensitivity [105]. The small
particle matrices/stationary phase material, specically developed to with-
stand high pressures, are mostly spherical particles of uniform size and classi-
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ed as either microporous supports, pellicular (supercially porous) supports
or bonded phases [105].
The mobile phase to be used to achieve sucient separation of analytes
during HPLC analysis can be either isocratic elution or gradient elution de-
pending on the separation required. It is also essential that all eluents be
degassed before use to prevent air bubbles in pumps [105].
HPLC has become the preferred method for routine carbohydrate analyses
due to its separation and quantication abilities, accuracy and rapidity but
is limited due to the absence of a chromophore in carbohydrates [111]. For
carbohydrate analysis, the detection methods usually coupled to HPLC are
refractive index (RI) detection, MS detection and pulsed amperometric detec-
tion (PAD) [112]. For RI the concentration detection limit is around 10−1 ppm
and for PAD it is more or less 10−2 ppm [112].
6.1.1.2 Radiolabeling and isotopic markers
Radiolabeled carbohydrates are commonly used to investigate the quantity
and properties of carbohydrates, especially after chromatographic separation.
14C labeled mono-, di-, or oligosaccharides are commercially available and ra-
diation studies with these provide a sensitive and relatively straight forward
alternative to investigate the in vitro metabolism [113], fermentation [114] and
general properties of carbohydrates. In this study, radiolabelled lactose will
be used to investigate the substrate binding ability and remaining activity of
the immobilised enzyme.
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6.2 Materials and Methods
6.2.1 Reagents and chemicals
Wildtype and E537D β-Gal were covalently immobilised to uidMAG-Amine
(200 nm) through glutaraldehyde and EDC strategies, as previously described.
Equal amounts of β-Gal (55 µg, 0.090 ml of 1 mg/ml), whether the wildtype or
the mutated version, were immobilised to 1 mg uidMAG-Amine using both
glutaraldehyde cross-linking and EDC coupling prior to activity investigations.
Radiolabeled Lactose (D-glucose-1-14C) (America Radiolabeled Chemicals,
Inc., St.Louis) and a Sugar-Pak I P/N 85188 column (Millipore, WATERS
(WAT085188)) as well as ONPG (Sigma-Aldrich Chemical Co., Germany) were
purchased for characterization purposes. All chemicals used for the prepara-
tion of buers and solutions were of analytical grade or higher and purchased
from Merck, Sigma-Aldrich Chemical Co. or Bio-Rad. An Ultra Pure Milli-Q
water system was used to produce reagent grade water used in all buers and
experiments
6.2.2 Detergent wash optimization
As mentioned previously, SDS is a strong detergent and might result in pro-
tein denaturation and loss of enzymatic activity. Two other less stringent
detergents, Tween-20 and Tween-80, were therefore compared to SDS for the
desorption of non specic adsorbed protein.
For this purpose, the puried wildtype β-Gal was used because the en-
zymatic activity is much higher when compared to the mutated enzyme and
as a result the colour reaction, with ONPG as substrate, is more easily visible
to the naked eye.
Three groups of immobilised samples, each consisting of six glutaralde-
hyde cross-linked wildtype β-Gal to uidMAG-Amine samples as well as six
EDC coupled wildtype β-Gal to uidMAG-Amine samples, were prepared as
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described in Chapter 5, 55 µg of protein immobilised to 1 mg uidMAG-
Amine. After the completion of the coupling and accompanying wash steps,
the samples were washed with the detergents in duplicate, therefore, two glut-
araldehyde immobilised samples of each group were washed with SDS, two with
Tween-20 and two with Tween-80, using the same protocol. The identical pro-
tocol was followed for the three groups of six EDC immobilised samples. The
detergent wash was therefore performed with a 2 % solution of either SDS,
Tween-20 or Tween-80 in PBS buer, pH 7.4, whereas the incubation times
and temperatures of the three groups of samples diered. It was 1 hour with
gentle mixing at either ambient temperature or 50 oC or overnight at 4 oC.
Afterwards, the protein-uidMAG-Amine complexes were separated from
the detergent wash solution through magnetic decantation and the wash solu-
tion collected for a BCA protein determination assay. The protein-uidMAG-
Amine complexes were washed with, and resuspended, in PBS buer, pH 7.4
(100 µl), before the activity assays were conducted.
For the activity assays, ONPG, at a nal concentration of 13.3 mM, dis-
solved in Novo buer pH 6.5 (Novo, commercial information 1979) was used.
NOVO buer is a buer designed to reproduce the composition of milk (2.7 mM
sodium citrate, 7.91 mM citric acid, 2.99 mM potassium biphosphate, 10.84
mM potassium phosphate, 19.43 mM potassium hydroxide, 4.08 mM mag-
nesium chloride, 5.1 mM calcium chloride and 3.33 mM sodium carbonate)
[59]. β-Gal enzymatic activity results in the same colour reaction previously
mentioned in section 3.2.4. The colour change is visible with the naked eye
and can be measured as absorbance at 420 nm.
The suspended protein-uidMAG-Amine complexes (undiluted1) were in-
cubated with the NOVO buer containing ONPG (120 µl) for 10 minutes at
1The reason for using undiluted protein-uidMAG-Amine complexes was the following:
it is impossible to dilute the complexes, have a uniform dispersion and repeatably pipette
equal amounts of the diluted complexes due to the continuous precipitation of the particles.
The assay absorbencies for the dierent detergent washes was, however, comparable since
the assay conditions were kept constant for all the samples.
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37 oC whereafter the complexes were separated from the supernatant through
magnetic decantation and the supernatant added to a microplate and ana-
lyzed at 420 nm. For the assay, a blank, as well as a unimmobilised wildtype
β-Gal incubated with the substrate solution under the same conditions, were
included as a reference for enzymatic activity.
It is important to note that the unimmobilised/free enzyme could not be
separated from the assay buer and was therefore still present and active in
the microplate well. The suspended protein-uidMAG-Amine complexes were
not diluted as previously performed for the wildtype β-Gal ONPG assay (refer
to section 3.2.4).
6.2.3 Immobilised wildtype and E537D β-Gal
radioactive binding assay with radiolabelled
lactose (D-glucose-1-14C)
The immobilised radioactive binding assay was conducted similar to the assay
previously described by Dodd [4]. FluidMAG-Amine EDC and glutaralde-
hyde immobilised wildtype and E537D β-Gal samples were incubated with
a 0.2 nmol radiolabeled lactose (D-glucose-1-14C) solution in NOVO buer,
pH 6.5, for 5 minutes at room temperature in triplicate. The immobilised
enzyme-particle samples were then removed from the solution via magnetic
decantation. The original 0.2 nmol radiolabeled lactose solution as well as the
residual supernatant solution, after incubation with the immobilised enzyme-
particles, were analyzed with a scintillation counter. Several experimental
control samples were also included i.e. samples containing uidMAG-Amine
but no protein, samples not incubated with D-glucose-1-14C as well as a wash
step of all the samples after incubation with D-glucose-1-14C to remove any
non-specic binding of D-glucose-1-14C to the enzyme.
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6.2.4 Immobilised enzymatic assay with ONPG
The presence of activity in the EDC and glutaraldehyde immobilised wildtype
β-Gal was indicated with ONPG, at a nal concentration of 13.3 mM, dissolved
in Novo buer, pH 6.5, at 37 oC for 5 minutes.
As previously mentioned, the unimmobilised/free enzyme (wildtype β-Gal)
could not be separated from the assay buer and remained active in the mi-
croplate well. This was therefore not an accurate comparison between free
and immobilised enzyme for the calculation of retained enzymatic activity but
the two immobilisation strategies could be compared due to consistent exper-
imental conditions.
6.2.5 Radioactive Partition HPLC
The lactose hydrolysis activity of the immobilised wildtype and E537D β-
Gal, as well as the mutant's potential to physically remove lactose from a
lactose containing solution, was determined by Radioactive Partition HPLC
analysis. All HPLC analyses were performed on a SpectraSYSTEM P4000
high performance liquid chromatograph (Thermo SeparationTM products, San
Jose, CA, USA) coupled to a SpectraSYSTEM AS3000 automatic injector
(Thermo SeparationTM products, San Jose, CA, USA) and a Flo-One liquid
scintillation spectrophotometer (Radiomatic, Tampa, FL, USA). A Sugar-Pak
I column was used and operated at 70 oC. The HPLC was controlled with
ChromQuest version 2.53 ((1998-1999) ThermoQuest Corporation) computer
software.
The column was equilibrated according to manufacturer's instructions with
a 0.001 M calcium EDTA solution (500 mg/L)(100 ml) at a ow rate of 0.5
ml/min at 70 oC. The mobile phase for sample analysis was a solution of 0.1
mM calcium EDTA (50 mg/L) kept between 70 and 80 oC and operated at
a ow rate of 0.6 ml/min. The scintillation uid was added at a ow rate of
three times that of the mobile phase for radioactive detection.
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The activity assays were carried out as described in section 6.2.3 with the
residual supernatant analyzed by HPLC instead of the scintillation counter.
6.3 Results and Discussion
6.3.1 Investigation into the most ecient detergent for
the desorption of non-specic adsorbed protein
Activity of the suspended protein-uidMAG-Amine complexes were investig-
ated with ONPG as substrate, dissolved in NOVO buer, pH 6.5, at 37 oC for
10 minutes and the activity measured as absorbance at 420 nm. Figure 6.1
is an evaluation of the three detergents used for the desorption of adsorbed
protein and compared regarding the percentage retained enzymatic activity
per mg protein immobilised in contrast to the enzymatic activity of the unim-
mobilised enzyme.
Enzymatic activity of all the detergent washed samples did not appear to
change signicantly when the wash step was performed at ambient temperat-
ure, however, when the wash step was performed at either 4 oC or 50 oC, the
activity was inuenced signicantly. At 50 oC the 2 % SDS wash denatured
the enzyme resulting in a complete loss of enzymatic activity (Figure 6.1). Re-
action conditions of 4 oC overnight inuenced not only the SDS washed sample
but also the activity of the EDC coupled Tween-washed samples. Interestingly
the glutaraldehyde cross-linked samples retained their activity.
These results revealed Tween-20 and -80 to be less detrimental than SDS
regarding retained enzymatic activity after wash steps performed at 4 oC,
ambient temperature and 50 oC. According to Van den Berg et al. [95], SDS has
the "best detergency power" and is able to remove most or all of the adsorbed
protein; Tween-80 on the other hand has very good detergent properties for the
prevention of protein adsorption, especially when included with glutaraldehyde
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Figure 6.1: Comparison between SDS, Tween-20 and Tween-80 regarding the per-
cent retained activity for the desorption of adsorbed protein after incubations at 4
oC, ambient temperature and 50 oC. Graphpad Prism 5 software was used for stat-
istical analysis. Columns were compared to the control column by one-way ANOVA,
followed by Dunnett's post test (***P < 0.05). GLUT = glutaraldehyde. Error bars
indicate SEM, n = 2.
in the reaction mixture. For the subsequent assays, Tween-20 was used as
detergent to desorb physically adsorbed protein.
6.3.2 Radioactive binding assay with radiolabelled
lactose (D-glucose-1-14C)
Radioactive binding assay data received from the scintillation counter were
compared regarding the percentage lactose bound per immobilised protein
sample and are summarized in Figure 6.2. Several controls were included,
as mentioned previously in section 6.2.3, to ensure reproducibility.
From the results summarized in Figure 6.2 it is evident that there is a
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Figure 6.2: Comparison between percent lactose binding per immobilised protein
sample via the two immobilisation strategies. The E537D β-Gal immobilised via
glutaraldehyde was able to bind approximately 34 % of the lactose present while
the E537D β-Gal immobilised via EDC was only able to bind approximately 8 % of
the lactose present. The wildtype β-Gal immobilised via glutaraldehyde and EDC
was also able to bind some of the lactose present. Graphpad Prism 5 software was
used for statistical analysis. Columns for the glutaraldehyde immobilised E537D
and wildtype β-Gal were compared by one-way ANOVA, followed by a t test (**P
< 0.05). Error bars indicate SEM, n = 3.
signicant dierence between the amount of lactose that E537D β-Gal, im-
mobilised via glutaraldehyde, can bind for prolonged periods (5 - 10 minutes)
as compared to that of the immobilised wildtype that has a signicantly higher
catalytic activity, which means the substrate is converted to the products as
soon as it is located to the active site. In addition, the glutaraldehyde im-
mobilised E537D β-Gal could bind approximately 34 % of 0.2 nmol lactose
while the EDC immobilised E537D β-Gal could only bind approximately 8
% of the lactose present. This suggests that the glutaraldehyde strategy for
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the covalent immobilisation of E537D β-Gal may result in a more functional
immobilised enzyme, capable of binding lactose more eciently than the EDC
immobilised strategy, when equal amounts of enzyme were immobilised to
uidMAG-Amine. This may also explain the dierence that can be seen, in
Figure 6.2, with glutaraldehyde between the mutant and wildtype, which is
not present in the EDC samples. Here, the EDC immobilised E537D β-Gal has
lost some of its substrate binding capabilities, possibly due to conformational
changes induced by the "zero-length" covalent coupling to the MNPs.
6.3.3 Immobilised enzymatic activity assay with ONPG
Observations during the assay indicated that the glutaraldehyde cross-linked
enzyme-particles retained more enzymatic activity when compared to the EDC
coupled enzyme-particles (yellow colour visible with the naked eye). This
observation was conrmed by a spectrophotometric measurement at 420 nm.
Figure 6.3 is a representation of the percentage retained activity, which
is comparable between the two immobilisation strategies. The data indic-
ated that the glutaraldehyde cross-linked enzyme-particles retained more than
twice the percentage retained enzymatic activity of the EDC coupled enzyme-
particles. This again suggested that the glutaraldehyde immobilisation strategy
might result in a more functionally immobilised enzyme compared to the EDC
immobilisation strategy for the coupling of β-Gal to uidMAG-Amine.
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Figure 6.3: Comparison between percentage retained activity between glutaralde-
hyde and EDC immobilised wildtype β-Gal as investigated with ONPG as substrate
at 420 nm. Graphpad Prism 5 software was used for statistical analysis. Columns
were compared by a t test (**P < 0.05). Error bars indicate SEM, n = 3.
6.3.4 Immobilised enzymatic activity assay with
radiolabelled lactose (D-glucose-1-14C) -
Radioactive Partition HPLC
Partition HPLC analysis with radioactive detection was used to separate the
radiolabeled lactose (disaccharide sugar) and glucose (monosaccharide sugar)
to allow distinction between the removal of lactose by the enzyme-particle
complexes and hydrolysis to glucose and galactose.
6.3.4.1 Determination of retention times
The Sugar-Pak I column used for the separation of lactose and glucose in
this project, is a column generally used for the analysis of sugar products.
The column can be used to separate many monosaccharides, polyols and al-
cohols [115]. Larger sugars and disaccharides can also be separated according
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to molecular weight [115]. The 300 x 6.5 mm column was packed with a
microparticulate cation-exchange gel in calcium form and the manufacturer
instructions regarding proper handling, storage and operation were closely fol-
lowed. The chromatography of the 14C glucose standard, after separation on
the Sugar-Pak column, resulted in two peaks, one at 4.6 min and one at 8.3
min, while the retention time of 14C lactose (D-glucose-1-14C) was 6.67 min
as shown in Figure 6.4. The two peaks observed after 14C glucose separation
can be ascribed to the two naturally occurring α-D- and β-D-isomers present
at high temperatures.
Figure 6.4: Partition HPLC chromatograms of (a) 14C glucose and (b) 14C lactose
on a Sugar-Pak I column operated between 70 and 80 oC with 0.1 mM calcium EDTA
as mobile phase.
6.3.4.2 Partition HPLC of radioactive binding assay control and
supernatant samples
Supernatant samples of the radioactive binding assay, as explained in section
6.2.3, were added to HPLC autosampler viles (12 x 32 mm) tted with inserts
and 8 mm septa. The partition of each sample was compared to the partition
of an experimental control i.e. the supernatant after incubation of 0.2 nmol ra-
diolabeled lactose (D-glucose-1-14C) with uncoated "naked" uidMAG-Amine.
Consequently, any dierence observed in carbohydrate separation or detected
radioactive counts between the supernatant samples and the control can be
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ascribed to the particular β-Gal coating, whether it is the E537D or wildtype
β-Gal.
The calculated integrated peak area of lactose, obtained with partition
HPLC separation of the experimental control sample, shown in Figure 6.5,
averaged at 31486 CPM as calculated by the HPLC Flow-One/Beta Data
Acquisition version 2.0 ((19/08/2008) K. Visser) computer software program.
This was taken as 100 % for the subsequent calculations of the percentage
lactose bound.
Figure 6.5: Partition HPLC chromatogram of the radiolabeled lactose experimental
control sample on a Sugar-Pak I column operated between 70 and 80 oC with 0.1
mM calcium EDTA as mobile phase.
The chromatograms of the partition HPLC separation of the supernatant
samples obtained after the incubation of radiolabeled lactose with the uidMAG-
Amine EDC and glutaraldehyde immobilised wildtype and E537D β-Gal samples
are shown in Figure 6.6(a)-(d). The supernatant removed from the uidMAG-
Amine containing the immobilised E537D β-Gal (Figure 6.6(a) EDC and (b)
Glutaraldehyde) yielded chromatograms with single peaks that agree with the
retention time of lactose. The absence of additional peaks in the chromato-
grams indicate that no detectable hydrolysis of lactose occurred during this 5
minute incubation. In contrast, the supernatant removed from the uidMAG-
Amine containing the immobilised wildtype β-Gal (Figure 6.6(c) EDC and
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(d) Glutaraldehyde) yielded chromatograms with peaks that agree with the
retention times of only the glucose isomers. This suggests that the 5 minute
incubation period with the immobilised wildtype samples allowed complete
hydrolysis of the 0.2 nmol lactose that was present in the solution.
The calculated integrated peak area for the EDC immobilised E537D β-
Gal averaged at 28646 CPM compared to 21253 CPM for the glutaraldehyde
immobilised E537D β-Gal. These values were used to calculate the percent
lactose binding per sample.
Figure 6.6: Partition HPLC chromatograms of supernatant samples obtained after
incubation of radiolabeled lactose with uidMAG-Amine immobilised (a) E537D β-
Gal via EDC, (b) E537D β-Gal via glutaraldehyde, (c) wildtype β-Gal via EDC and
(d) wildtype β-Gal via glutaraldehyde on a Sugar-Pak I column operated between
70 and 80 oC with 0.1 mM calcium EDTA as mobile phase.
6.3.4.3 Percent lactose binding
The percent lactose binding per immobilised E537D β-Gal sample was calcu-
lated and is summarised in Figure 6.7. It was calculated that the uidMAG-
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Amine immobilised E537D β-Gal via glutaraldehyde can bind and remove
approximately 33 % of the lactose present in a 0.2 nmol solution while the
EDC immobilised samples were only able to bind and remove approximately
9 % of the lactose present. These results obtained with radioactive partition
HPLC, therefore, agree with the results from the samples analyzed by the scin-
tillation counter, Figure 6.2. It is therefore evident that the glutaraldehyde
immobilised E537D β-Gal can bind and remove signicantly more lactose from
solution than the EDC immobilized enzyme. These results conrmed the pre-
vious ndings that glutaraldehyde is the preferred method for the functional
immobilisation of β-Gal to uidMAG-Amine.
Figure 6.7: Comparison between percent lactose binding per immobilised E537D
β-Gal sample via the two immobilisation strategies. The E537D β-Gal immobilised
via glutaraldehyde was able to bind approximately 33 % of the lactose present while
the E537D β-Gal immobilised via EDC was only able to bind approximately 9 %
of the lactose present. Graphpad Prism 5 software was used for statistical analysis.
Columns for the glutaraldehyde and EDC immobilised E537D β-Gal were compared
by a t test (**P < 0.05). Error bars indicate SEM, n = 2.
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6.4 Conclusion
The retained activity of the uidMAG-Amine immobilised E537D β-Gal via
EDC and glutaraldehyde was investigated and, from the presented results, the
glutaraldehyde strategy for covalent immobilisation of β-Gal was preferred.
The glutaraldehyde strategy produced a more functionally immobilised en-
zyme, able to bind and remove more lactose from solution, when compared to
the EDC strategy. The covalently immobilised E537D β-Gal was also able to
remove twice (34 %) the amount of lactose as the physical adsorption method
(15 %) (Figures 6.2 and 6.7) previously investigated in our laboratory [4].





Lactose free dairy products, or products with reduced lactose content, are
in great demand world wide, since the majority of the world's population is
lactose intolerant. This intolerance is as a result of a deciency in the lactase
enzyme produced in the small intestine. The large demand for lactose free
products has encouraged researchers internationally to develop methods for
the production of lactose free products on an industrial scale.
Current practice, for the production of lactose free products, include the
hydrolysis of lactose to glucose and galactose by the addition of free, β-Gal or
through so called bed reactors (refer to section 2.6.2). In the former method,
it is custom to leave the added β-Gal enzyme in the milk after complete hy-
drolysis of the lactose as there is no facile technology available to remove the
enzyme from the milk. The resulting lactose free product, produced by the
addition of β-Gal, is excessively sweet due to the higher relative sweetness of
glucose and galactose when compared to lactose. The excessive sweet taste is
perceived as negative by the majority of consumers.
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The lack of a practical and economical technology for the removal of lactose
from milk, with the retention of the natural sweetness of the product, was the
motivation for the development of a novel method for lactose removal from
milk on an industrial scale.
7.1.1 β-Galactosidase
A number of sources for β-Gal have been indentied [9]. For the purpose
of this study, E. coli was the source selected. The reasoning behind this
selection was the fact that the genome of E. coli has been sequenced, it is
a well characterized model organism for recombinant protein expression and
most applications of this organism have already been optimized. Although
E. coli does not have a generally recognized as safe (GRAS) status, it was
an acceptable source for β-Gal since this study was still part of the proof of
concept for the development of this novel technique to remove lactose from
milk and not the nal prototype. When considering the implementation of
this novel technique in the food processing industry, attention must be given
to the selection of an appropriate source of the enzyme. The appropriate
source organism must have GRAS status, like Saccharomyces, Lactobacillus
acidophilus, L. bulgaricus, L. lactis, L. delbrueckii and Bacillus circulans to
ensure general acceptance by the public as well as compliance with current
good manufacturing practices (GMP).
The Lac Z gene of E. coli was eectively cloned into the pTrcHis-TOPO
plasmid and the E537D mutant was prepared as previously mentioned [4].
When expressed, these His-tagged constructs resulted in highly reproducible
purication yields with IMAC (Figure 3.3). The results obtained after kinetic
characterization of the pure wildtype and E537D β-Gal (Table 3.1) were similar
to those previously achieved [4], with the mutant only retaining about 0.0146
times the activity of the wildtype while the substrate binding ability was not
signicantly altered.
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7.1.2 Structural investigation of β-Gal
The three dimensional structure and topography investigation of the basic
(Lys, Arg and His) and acidic (Asp and Glu) amino acid residues on the surface
of β-Gal (Figure 4.6), as well as calculations regarding their abundance (Table
4.1), identied both the amine and carboxyl groups of β-Gal to be equally
accessible for targeting during covalent coupling.
7.1.3 Covalent immobilisation of β-Gal via EDC and
glutaraldehyde
The random covalent coupling of pure E537D β-Gal to uidMAG-Amine was
successfully achieved with both EDC and glutaraldehyde. EDC is a coup-
ling agent that produces "zero-length" cross-linking, while glutaraldehyde is
a cross-linking agent with a multi-component nature depending on the reac-
tion conditions. Glutaraldehyde acts as a spacer when cross-linking protein
and particles and ,therefore, limits structural hindrances. This covalent link
between the protein and MNPs prevented enzyme leakage from the beads and
added stability to the complex.
Optimization of the amount of protein coupled to uidMAG-Amine, in-
dicated that, when glutaraldehyde was used as the cross-linking agent, more
protein could be coupled to the particles compared to the EDC method. The
covalent coupling was veried and visualized experimentally via a range of
verication methods including microscopy. It was apparent that gluaraldehyde
was the more appropriate selection for the random covalent immobilisation of
E537D β-Gal to uidMAG-Amine, since it allowed for an increased carrier ca-
pacity of protein to the particles, which is possibly due to its multi-component
nature [98].
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7.1.4 Enzymatic activity of immobilised β-Gal
Initial analyses of the β-Gal-uidMAG-Amine complex indicated non-specic
protein binding to the nanoparticles at high protein concentrations (Figures
5.4 and 5.5). The non-specic binding was conrmed by SDS treatment of
the complexes that removed non-covalently bound proteins from the particles,
allowing a more accurate estimation of the covalent coupling of protein to the
particles. As SDS is a harsh detergent, which lead to protein denaturation and
inactivation, the detergents Tween-20 and -80 were investigated as alternative
for the removal of non-specically bound protein. These two detergents were
less harsh than SDS for the desorption of non-covalently adsorbed protein and
this was in agreement with observations made previously by Van den Berg et
al. [95].
A comparison of the hydrolytic activity of the EDC and glutaraldehyde
immobilised wildtype β-Gal, using ONPG as substrate, showed that the glut-
araldehyde immobilised protein exhibited a two-fold higher activity than the
EDC coupled protein (Figure 6.3), suggesting that, during glutaraldehyde
cross-linking, the protein may be less prone to denaturation or conformational
changes. EDC, on the other hand, appeared to inuence these critical prop-
erties of β-Gal during coupling to uidMAG-Amine. The activity of E537D
β-Gal after immobilisation to uidMAG-Amine was also investigated and it
was found that this has denitely decreased but there were still enough activity
left to ensure substrate binding and limited hydrolysis.
In accordance with the results obtained with the immobilised wildtype
enzyme, the radioactive binding assay with radiolabelled lactose (D-glucose-1-
14C) demonstrated that the glutaraldehyde cross-linked E537D β-Gal-uidMAG-
Amine complex could physically bind and remove signicantly more lactose
than the EDC coupled complex. The glutaraldehyde cross-linked uidMAG-
E537D β-Gal was able to physically remove 34 % of the lactose from a 0.2
nmol/L lactose in solution. This was without any hydrolysis to the monosac-
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charide sugars (glucose and galactose), while the glutaraldehyde cross-linked
uidMAG-wildtype β-Gal had, in the same incubation period, hydrolyzed all
the lactose of the 0.2 nmol/L lactose solution (Figure 6.6). The 34 % lactose
that the glutaraldehyde cross-linked uidMAG-E537D β-Gal was able to re-
move, could be equated to approximately 0.07 nmol lactose bound per 1 mg
uidMAG-Amine containing an E537D β-Gal surface coating equal to 55 µg
protein.
The immobilisation of a mutated form of β-Gal, on functionalized mag-
netic nanoparticles, was successful and could bind lactose and remove it from
solution. The question that now needs to be addressed is the capacity of the
complex to remove lactose from milk. When the lactose binding capacity, ob-
tained in this study, is scaled up theoretically, it suggests that 1 kg of E537D
β-Gal coated uidMAG-Amine would be able to bind and remove approxim-
ately 0.070 mmol of lactose from solution. The lactose content of milk is in
the order of 133 mmol/L and therefore suggests that over 900 incubation steps
of 1 L milk with 1 kg nanoparticles would be necessary to reduce the lactose
content by half.
In summary: The preceding discussion detailed the research objectives
that were fullled experimentally. Specically, it was shown that recombinant
expressed and IMAC puried wildtype and E537D β-Gal could be covalently
immobilised to commercially available uidMAG-Amine through both EDC
coupling and glutaraldehyde cross-linking. Glutaraldehyde was shown to be
the preferred cross-linking agent for the MNP immobilisation of E537D β-Gal.
It is apparent that this technology, at the current level of development, is
not yet suited for industrial application. The idea itself is, however, novel and
viable and a number of suggestions for future research and process optimization
will be discussed.
Some of the methods and results of Dodd [4] were replicated during this
study. These include wildtype and E537D β-Gal protein expression, IMAC
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protein purication and β-Gal enzymatic activity determinations. However,
Dodd made use of a physical adsorption, non-covalent, strategy (IMAC) to
immobilise β-Gal to commercially available MNPs. This has shortcomings in
that the link between the enzyme and solid support is not very strong and
permanent, and might result in enzyme leakage. This investigation, however,
made use of covalent cross-linking strategies to immobilise β-Gal to commer-
cially available MNPs. This provides advantages, in that enzyme leakage was
prevented. The new strategy incorporated was also able to bind and physically
remove more lactose in comparison with Dodd's strategy [4].
7.2 Future research and recommendations
Solid supports, enzymes and immobilisation/coupling chemistries are rapidly
expanding elds of study and therefore present a variety of opportunities for
further improvements and applications. Due to the multi-disciplinary nature
of this project, as well as the demand for the industrial production of lactose
free products in the food process industry, the following areas for improvement
are suggested.
7.2.1 MNPs
Commercially available MNPs were easy to obtain for the purpose of this study
but expensive when considering the bulk production of protein coated particles.
The synthesis of these magnetite nanoparticles is, however, not complicated
or technically challenging. It would be more economical and practical, to
develop tailor made particles for specic use in the dairy industry. The surface
coating of the magnetite core, to functionalize the particles for covalent protein
binding, is probably the more challenging component of MNP synthesis, but
has progressed considerably at the Department of Chemistry and Polymer
Science at the University of Stellenbosch where polymers for the facile non
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covalent attachment of proteins have been developed [116].
7.2.2 The nanoparticle size and surface chemistry
The smaller the MNP size, the bigger the surface area to volume ratio and
subsequently the capacity for the coupling of more protein per mg MNP. It is
therefore important to synthesize MNPs with the smallest consistent size pos-
sible under controlled experimental conditions before applying surface chem-
istry to functionalize the particles for protein coupling.
The random covalent coupling of enzymes inuences the substrate binding
and catalytic abilities, as discussed in Chapter 6. Directed covalent anchoring
of β-Gal to MNPs would limit the conformational changes and may even im-
prove the accessibility of the active site for substrate binding, depending on
the directed anchoring method applied. According to Teste et al. [58], the dir-
ected anchoring of biomolecules are more reproducible than random methods.
The directed covalent anchoring of biomolecules also allow for coupling in an
orderly fashion as well as the use of linkers or spacers to limit conformational
changes and steric hindrances [61].
A directed covalent anchoring method that could be attempted in the future
is described by Pessela et al. [59]. These authors described the use of "novel
heterofunctional chelate-epoxy sepabeads". The surface chemistry of these
beads consisted of a low concentration of metal chelated groups and a high
density of epoxy groups [59]. These heterofunctional beads allowed for the
selective adsorption of poly-His-tagged proteins through IMAC chemistry to
the chelated groups whereafter the selective covalent coupling was introduced
through interactions with the epoxy groups [59].
7.2.3 Lactose binding protein - size considerations
The large size (464 kDa) of β-Gal limits the amount of enzyme that can be
immobilised to the surface of MNPs and ultimately the amount of lactose
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bound and removed. Considering the use of another enzyme, able to bind
lactose, with a signicantly smaller molecular mass would potentially allow for
more enzyme to be coupled to per mg of MNPs, and subsequently increase
the ability to bind and remove more lactose from solution. Although there is
currently no other enzyme known to be able to bind and hydrolyze lactose,
a number of disaccharide binding enzymes exist, which could be investigated
and mutated to obtain lactose binding.
In conclusion: The investigation into and implementation of some or all of
the above mentioned recommendations for the optimization of this novel tech-
nique could result in the development of technology that would allow for the
removal of lactose from milk and the production of lactose free dairy products,
or products with reduced lactose content, on an industrial scale.
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